{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2\n",
    "import bert\n",
    "import numpy as np\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "import matplotlib.pyplot as plt\n",
    "import spike_queries\n",
    "from termcolor import colored\n",
    "import random\n",
    "from collections import Counter, defaultdict\n",
    "from viterbi_trellis import ViterbiTrellis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "class color:\n",
    "   PURPLE = '\\033[95m'\n",
    "   CYAN = '\\033[96m'\n",
    "   DARKCYAN = '\\033[36m'\n",
    "   BLUE = '\\033[94m'\n",
    "   GREEN = '\\033[92m'\n",
    "   YELLOW = '\\033[93m'\n",
    "   RED = '\\033[91m'\n",
    "   BOLD = '\\033[1m'\n",
    "   UNDERLINE = '\\033[4m'\n",
    "   END = '\\033[0m'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_results(fname):\n",
    "    \n",
    "    with open(fname, \"r\", encoding = \"utf-8\") as f:\n",
    "        sents = f.readlines()\n",
    "    \n",
    "    sents = [s.strip().replace(\"<s1>\",\"\").replace(\"<s2>\",\"\").replace(\"<e1>\", \"\").replace(\"<e2>\",\"\").replace(\"h:\",\"\").\n",
    "             split(\"\\t\")[-1] for s in sents]\n",
    "    original, results = sents[0], sents[1:]\n",
    "    return original, results\n",
    "\n",
    "\n",
    "def get_spike_results_arguments_representations(model, spike_results, layers):\n",
    "    \n",
    "    sents = spike_results[\"sentence_text\"].tolist()\n",
    "    arg1_idx_start = spike_results[\"arg1_first_index\"].to_numpy().astype(int)\n",
    "    arg2_idx_start = spike_results[\"arg2_first_index\"].to_numpy().astype(int)\n",
    "    arg1_idx_end = spike_results[\"arg1_last_index\"].to_numpy().astype(int)\n",
    "    arg2_idx_end = spike_results[\"arg2_last_index\"].to_numpy().astype(int)\n",
    "    \n",
    "    arg1_rep = []\n",
    "    arg2_rep = []\n",
    "    \n",
    "    for s, arg1_start, arg2_start, arg1_end, arg2_end in zip(sents, arg1_idx_start, arg2_idx_start, arg1_idx_end, arg2_idx_end):\n",
    "        #idx_to_mask = [arg1_start, arg2_start, arg1_end, arg2_end]\n",
    "        H, _, _, orig2tok = model.encode(s, layers = layers)\n",
    "\n",
    "        h1, h2 = H[orig2tok[arg1_start]:orig2tok[arg1_end] + 1], H[orig2tok[arg2_start]:orig2tok[arg2_end] + 1]\n",
    "        \n",
    "        h1 = np.mean(h1, axis = 0)\n",
    "        h2 = np.mean(h2, axis = 0)\n",
    "        \n",
    "        arg1_rep.append(h1)\n",
    "        arg2_rep.append(h2)\n",
    "        \n",
    "    arg1_mean = np.mean(arg1_rep, axis = 0)\n",
    "    arg2_mean = np.mean(arg2_rep, axis = 0)\n",
    "        \n",
    "    return arg1_mean, arg2_mean\n",
    "    \n",
    "\n",
    "def print_sentence_nicely(sentence: str, ind1, ind2):\n",
    "    \n",
    "    arg1_sign = \"**\"\n",
    "    arg2_sign = \"++\"\n",
    "    arg1_color, arg2_color = \"red\", \"blue\"\n",
    "    \n",
    "    if not ind2 > ind1: \n",
    "        ind1, ind2 = ind2, ind1\n",
    "        arg1_sign, arg2_sign = arg2_sign, arg1_sign\n",
    "        arg1_color, arg2_color = arg2_color, arg1_color\n",
    "        \n",
    "    splitted = sentence.split(\" \")\n",
    "    before_arg1 = \" \".join(splitted[:ind1])\n",
    "    arg1 = splitted[ind1]\n",
    "    arg2 = splitted[ind2]\n",
    "    between = \" \".join(splitted[ind1 + 1: ind2])\n",
    "    suffix = \" \".join(splitted[ind2+1:])\n",
    "    \n",
    "    return before_arg1 +  \" \" + arg1_sign + colored(arg1, arg1_color) + arg1_sign + \" \" + between + \" \" + arg2_sign + colored(arg2, arg2_color) + arg2_sign + \" \" + suffix\n",
    "\n",
    "\n",
    "\n",
    "def main(filename, layers = [-1], num_results_to_print = 75):\n",
    "    \n",
    "    \n",
    "    query, results1 = load_results(filename)\n",
    "    spike_results = spike_queries.perform_query(query, dataset_name = \"covid19\", num_results = 100, query_type = \"syntactic\")\n",
    "    spike_results = spike_results[spike_results['sentence_text'].notnull()]\n",
    "    arg1_rep, arg2_rep = get_spike_results_arguments_representations(model, spike_results, layers)\n",
    "    \n",
    "    #print(color.BOLD + \"QUERY\" + color.END + \":\\n{}\".format(query))\n",
    "    \n",
    "    first, first_ind1, first_ind2 = spike_results[\"sentence_text\"].tolist()[-1], int(spike_results[\"arg1_first_index\"].tolist()[-1]), int(spike_results[\"arg2_first_index\"].tolist()[-1])\n",
    "    #print(color.BOLD + \"\\nFIRST SPIKE RESULT\" + color.END + \":\\n{}\".format(print_sentence_nicely(first, first_ind1, first_ind2)))\n",
    "    #print(color.BOLD + \"\\nAUGMENTATION RESULTS:\\n\" + color.END)\n",
    "    \n",
    "    representations = []\n",
    "    mappings_to_orig = []\n",
    "    mappings_to_tok = []\n",
    "    tokenized_txts = []\n",
    "    orig_sents = []\n",
    "    \n",
    "    for i,s in enumerate(results1):\n",
    "        H, tokenized_text, tok_to_orig_map, orig2tok = model.encode(s, layers = layers)\n",
    "        orig_sents.append(s)\n",
    "        representations.append(H)\n",
    "        mappings_to_orig.append(tok_to_orig_map)\n",
    "        mappings_to_tok.append(orig2tok) \n",
    "        tokenized_txts.append(tokenized_text)\n",
    "        \n",
    "        if i > num_results_to_print: break\n",
    "    \n",
    "    return query, (arg1_rep, arg2_rep), (representations, mappings_to_orig, mappings_to_tok, tokenized_txts, orig_sents)\n",
    "\n",
    "\n",
    "def get_between_tokens_similarity(padded_representations):\n",
    "    \n",
    "    num_sents, seq_len, bert_dim = padded_representations.shape\n",
    "    padded_representations = padded_representations.reshape((num_sents*seq_len, bert_dim))\n",
    "    sims = cosine_similarity(padded_representations, padded_representations)\n",
    "    sims = sims.reshape((num_sents, seq_len, num_sents, seq_len))\n",
    "    \n",
    "    return sims\n",
    "\n",
    "def get_between_token_similarity_prev_sentence(padded_representations):\n",
    "    \n",
    "    num_sents, seq_len, bert_dim = padded_representations.shape\n",
    "    padded_representations = padded_representations.reshape((num_sents*seq_len, bert_dim))    \n",
    "    padded_representations /= np.linalg.norm(padded_representations, keepdims = True, axis=1)\n",
    "    padded_representations = padded_representations.reshape((num_sents, seq_len, bert_dim))\n",
    "    tuples = list(zip(padded_representations, padded_representations[1:]))\n",
    "    sims = np.array([tup[0].dot(tup[1].T) for tup in tuples])\n",
    "    sims = sims.reshape(((num_sents-1)*seq_len, seq_len))\n",
    "    return sims\n",
    "\n",
    "def get_similarity_to_arguments(padded_representations, arg1, arg2):\n",
    "    num_sents, seq_len, bert_dim = padded_representations.shape\n",
    "    padded_representations = padded_representations.reshape((num_sents*seq_len, bert_dim))\n",
    "    #print(padded_representations.shape)\n",
    "    sims = cosine_similarity([arg1_rep, arg2_rep], padded_representations)\n",
    "    sims = sims.reshape((2, num_sents, seq_len))\n",
    "    return sims"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "loading configuration file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/config.json from cache at /home/shauli/.cache/torch/transformers/199e28e62d2210c23d63625bd9eecc20cf72a156b29e2a540d4933af4f50bda1.4b6b9f5d813f7395e7ea533039e02deb1723d8fd9d8ba655391a01a69ad6223d\n",
      "Model config BertConfig {\n",
      "  \"attention_probs_dropout_prob\": 0.1,\n",
      "  \"hidden_act\": \"gelu\",\n",
      "  \"hidden_dropout_prob\": 0.1,\n",
      "  \"hidden_size\": 768,\n",
      "  \"initializer_range\": 0.02,\n",
      "  \"intermediate_size\": 3072,\n",
      "  \"layer_norm_eps\": 1e-12,\n",
      "  \"max_position_embeddings\": 512,\n",
      "  \"model_type\": \"bert\",\n",
      "  \"num_attention_heads\": 12,\n",
      "  \"num_hidden_layers\": 12,\n",
      "  \"output_hidden_states\": true,\n",
      "  \"pad_token_id\": 0,\n",
      "  \"type_vocab_size\": 2,\n",
      "  \"vocab_size\": 31090\n",
      "}\n",
      "\n",
      "loading configuration file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/config.json from cache at /home/shauli/.cache/torch/transformers/199e28e62d2210c23d63625bd9eecc20cf72a156b29e2a540d4933af4f50bda1.4b6b9f5d813f7395e7ea533039e02deb1723d8fd9d8ba655391a01a69ad6223d\n",
      "Model config BertConfig {\n",
      "  \"attention_probs_dropout_prob\": 0.1,\n",
      "  \"hidden_act\": \"gelu\",\n",
      "  \"hidden_dropout_prob\": 0.1,\n",
      "  \"hidden_size\": 768,\n",
      "  \"initializer_range\": 0.02,\n",
      "  \"intermediate_size\": 3072,\n",
      "  \"layer_norm_eps\": 1e-12,\n",
      "  \"max_position_embeddings\": 512,\n",
      "  \"model_type\": \"bert\",\n",
      "  \"num_attention_heads\": 12,\n",
      "  \"num_hidden_layers\": 12,\n",
      "  \"pad_token_id\": 0,\n",
      "  \"type_vocab_size\": 2,\n",
      "  \"vocab_size\": 31090\n",
      "}\n",
      "\n",
      "Model name 'allenai/scibert_scivocab_uncased' not found in model shortcut name list (bert-base-uncased, bert-large-uncased, bert-base-cased, bert-large-cased, bert-base-multilingual-uncased, bert-base-multilingual-cased, bert-base-chinese, bert-base-german-cased, bert-large-uncased-whole-word-masking, bert-large-cased-whole-word-masking, bert-large-uncased-whole-word-masking-finetuned-squad, bert-large-cased-whole-word-masking-finetuned-squad, bert-base-cased-finetuned-mrpc, bert-base-german-dbmdz-cased, bert-base-german-dbmdz-uncased, bert-base-finnish-cased-v1, bert-base-finnish-uncased-v1, bert-base-dutch-cased). Assuming 'allenai/scibert_scivocab_uncased' is a path, a model identifier, or url to a directory containing tokenizer files.\n",
      "loading file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/vocab.txt from cache at /home/shauli/.cache/torch/transformers/e3debd8fbdf40874753724814ee0520f612b577b26c8755bca485103b47cd3bc.60287becc5ab96d85a4bf377eb90feaf3b9c80d3b23e84311dccd3588f56d4fb\n",
      "loading file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/added_tokens.json from cache at None\n",
      "loading file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/special_tokens_map.json from cache at None\n",
      "loading file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/tokenizer_config.json from cache at None\n",
      "loading weights file https://cdn.huggingface.co/allenai/scibert_scivocab_uncased/pytorch_model.bin from cache at /home/shauli/.cache/torch/transformers/54e18c298451d3195ba8359e7a3fa2bc04c70c730c5b6744928278e67940eacb.7587182ea55c40bf7fd0961c1176c31fa22558da2bf20c199874fa5a8ecb4613\n"
     ]
    }
   ],
   "source": [
    "model = bert.BertEncoder(\"cuda\", \"scibert\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "def get_probable_alignments(sims_args, mappings_to_orig):\n",
    "    argument2sent2alignments = dict()\n",
    "    \n",
    "    \"\"\"\n",
    "    :param sims_args: similarity to arguments per query, shape: [2,num_sents,padded_sent_len]\n",
    "    :return: \n",
    "    \"\"\"\n",
    "    \n",
    "    for arg in range(2):\n",
    "        sent2alignments = dict()\n",
    "        for sent_ind in range(sims_args.shape[1]):\n",
    "            sorted_sims_idx = np.argsort(-sims_args[arg][sent_ind])\n",
    "            sorted_sims_vals = sims_args[arg][sent_ind][sorted_sims_idx]            \n",
    "            sorted_sims_idx_mapped = [mappings_to_orig[sent_ind][j] if j in mappings_to_orig[sent_ind] else -1 for j in sorted_sims_idx]\n",
    "            sent2alignments[sent_ind] = list(zip(sorted_sims_idx_mapped, sorted_sims_vals))\n",
    "        \n",
    "        argument2sent2alignments[arg] = sent2alignments\n",
    "\n",
    "    return argument2sent2alignments"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "nan"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "np.nan"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "scrolled": false
   },
   "outputs": [],
   "source": [
    "query2arg2preds = defaultdict(dict)\n",
    "\n",
    "for q in [1,2,4,5,6,7,8,9]:\n",
    "    \n",
    "    # collect representations of arguments & results\n",
    "    \n",
    "    fname = \"results{}.txt\".format(q)\n",
    "    query, (arg1_rep, arg2_rep), (representations, mappings_to_orig, mappings_to_tok, tokenized_txts, orig_sents)  = main(fname, layers = [-1])\n",
    "    for i in range(len(representations)): # zero cls, ., sep\n",
    "        representations[i][0][:] = np.random.rand()\n",
    "        representations[i][-1][:] = np.random.rand()\n",
    "        representations[i][-2][:] = np.random.rand()\n",
    "\n",
    "    \n",
    "    pad_width = max([len(s) for s in representations])\n",
    "    padded_representations = np.array([np.concatenate([r, -np.ones((pad_width-len(r), 768))]) for r in representations])\n",
    "\n",
    "    num_sents, seq_len, bert_dim = padded_representations.shape\n",
    "    num_tokens = num_sents * seq_len\n",
    "    sims_args = get_similarity_to_arguments(padded_representations, arg1_rep, arg2_rep) #(2, num_sents, padded_sent_len)\n",
    "    \n",
    "    arguments2sent2alignments = get_probable_alignments(sims_args, mappings_to_orig)\n",
    "    for arg in range(2):\n",
    "        dicts = [{\"sent\": orig_sents[i], \"pred_idx\": list(zip(*arguments2sent2alignments[arg][i]))[0], \n",
    "                \"preds_sims\":  list(zip(*arguments2sent2alignments[arg][i]))[1]} for i in range(num_sents)]\n",
    "        \n",
    "        \n",
    "        query2arg2preds[q][arg] = dicts"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Evalation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_gold():\n",
    "    query2sent2gold = defaultdict(dict)\n",
    "    \n",
    "    for query in [1,2,4,5,6,7,8,9]:\n",
    "        \n",
    "        fname = \"results{}.txt\".format(query)\n",
    "        \n",
    "        with open(fname, \"r\", encoding = \"utf-8\") as f:\n",
    "            sents = f.readlines()\n",
    "    \n",
    "        original, results = sents[0], sents[1:]\n",
    "        \n",
    "        sent2gold = defaultdict(dict)\n",
    "        query_stop = False\n",
    "        \n",
    "        for i,line in enumerate(results):\n",
    "            \n",
    "            if line.count(\"<s1>\") != line.count(\"<e1>\"):\n",
    "                print(line)\n",
    "                print(\"<<<<<ERROR>>>>>\", query, i)\n",
    "            if query_stop: break\n",
    "                \n",
    "            sent_data_relevant = []\n",
    "            sent_data_arg1 = []\n",
    "            sent_data_arg2 = []\n",
    "            \n",
    "            _, sent = line.strip().split(\"\\t\")\n",
    "            tokens = sent.split(\" \")\n",
    "            \n",
    "            found_start_arg1 = False\n",
    "            found_start_arg2 = False\n",
    "            start_arg1 = None\n",
    "            start_arg2 = None\n",
    "            \n",
    "            for j,tok in enumerate(tokens):\n",
    "                \n",
    "                if \"h:\" in tok:\n",
    "                    sent_data_relevant.append(j)\n",
    "                \n",
    "                if \"<s1>\" in tok:\n",
    "                    found_start_arg1 = True\n",
    "                    start_arg1 = j\n",
    "                elif \"<s2>\" in tok:\n",
    "                    found_start_arg2 = True\n",
    "                    start_arg2 = j\n",
    "                \n",
    "                if found_start_arg1 and \"<e1>\" in tok:\n",
    "                    \n",
    "                    sent_data_arg1.append((start_arg1, j))\n",
    "                    \n",
    "                    found_start_arg1 = False\n",
    "                    start_arg1 = None\n",
    "                    \n",
    "                if found_start_arg2 and \"<e2>\" in tok:\n",
    "                    \n",
    "                    sent_data_arg2.append((start_arg2, j))\n",
    "                    \n",
    "                    found_start_arg2 = False\n",
    "                    start_arg2 = None  \n",
    "            \n",
    "            sent2gold[i] = {\"arg1\": sent_data_arg1, \"arg2\": sent_data_arg2, \"relevant\": sent_data_relevant}\n",
    "                \n",
    "            if \"<s1>\" not in sent: \n",
    "                query_stop = True\n",
    "        \n",
    "        query2sent2gold[query] = sent2gold\n",
    "    return query2sent2gold\n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1 0\n",
      "Hepatotropic virus , like MHV-3 infection in mice , can induce exaggerated inflammation in the liver and cause life-threatening viral FH .\n",
      "['virus', 'viral', 'infection', 'can', '[c]mice', 'inflammation', 'cause', '[p]Hepatotropic', '[c]induce', 'liver']\n",
      "===========================\n",
      "1 0\n",
      "Hepatotropic virus , like MHV-3 infection in mice , can induce exaggerated inflammation in the liver and cause life-threatening viral FH .\n",
      "['inflammation', 'viral', 'can', '[p]liver', 'virus', 'mice', 'induce', 'life-threatening', 'cause', 'infection']\n",
      "===========================\n",
      "1 1\n",
      "In humans , CHIKV infections cause a debilitating disease with acute febrile illness and long-term polyarthralgia .\n",
      "['infections', 'CHIKV', 'disease', '[c]humans', '[c]In', 'acute', 'illness', 'a', 'with', ',']\n",
      "===========================\n",
      "1 1\n",
      "In humans , CHIKV infections cause a debilitating disease with acute febrile illness and long-term polyarthralgia .\n",
      "['disease', '[c]illness', '[p]acute', 'a', '[p]polyarthralgia', '[p]with', '[c]In', '[c]infections', '[c]humans', '[p]and']\n",
      "===========================\n",
      "1 2\n",
      "MERS-CoV induces acute pneumonia similar to that caused by SARS-CoV, and is sometimes accompanied with renal failure ( Danielsson and Catchpole , 2012 ; Zaki et al. , 2012 ) .\n",
      "['[c]MERS-CoV', 'acute', 'by', 'pneumonia', 'induces', 'is', '(', 'by', 'and', 'by']\n",
      "===========================\n",
      "1 2\n",
      "MERS-CoV induces acute pneumonia similar to that caused by SARS-CoV, and is sometimes accompanied with renal failure ( Danielsson and Catchpole , 2012 ; Zaki et al. , 2012 ) .\n",
      "['pneumonia', 'acute', 'is', '[p]induces', 'failure', '[p]renal', '[p](', 'with', '[c]MERS-CoV', '[c]similar']\n",
      "===========================\n",
      "1 3\n",
      "FIV infection causes progressive immunosuppression that results in the development of the acquired immunodeficiency syndrome ( AIDS ) in cats , which , similar to human HIV infection , increases susceptibility to secondary and opportunistic infections .\n",
      "['[c]infection', '[c]FIV', 'infection', 'HIV', 'progressive', 'causes', 'cats', 'that', 'and', 'human']\n",
      "===========================\n",
      "1 3\n",
      "FIV infection causes progressive immunosuppression that results in the development of the acquired immunodeficiency syndrome ( AIDS ) in cats , which , similar to human HIV infection , increases susceptibility to secondary and opportunistic infections .\n",
      "['[c]progressive', '[c]progressive', 'causes', 'immunosuppression', '[c]infection', 'that', 'cats', 'in', 'development', 'susceptibility']\n",
      "===========================\n",
      "1 4\n",
      "In humans , JEV infection can cause Japanese encephalitis ( JE ) with severe central nervous system disorders .\n",
      "['infection', 'JEV', 'can', ',', '[c]humans', '[c]In', 'cause', 'severe', 'with', '(']\n",
      "===========================\n",
      "1 4\n",
      "In humans , JEV infection can cause Japanese encephalitis ( JE ) with severe central nervous system disorders .\n",
      "['[c]severe', '[c]can', '[p]disorders', '[p]infection', 'with', '[p]central', '[p]In', '[c]nervous', 'humans', 'cause']\n",
      "===========================\n",
      "1 5\n",
      "In immunocompetent adults , primary infection with HHV-6 can produce a mononucleosis-like illness and , more rarely , severe disease , including encephalitis [ Stoeckle , 2000 ] .\n",
      "['infection', '[p]primary', 'can', '[c]In', 'with', 'illness', 'encephalitis', 'disease', '[', 'adults']\n",
      "===========================\n",
      "1 5\n",
      "In immunocompetent adults , primary infection with HHV-6 can produce a mononucleosis-like illness and , more rarely , severe disease , including encephalitis [ Stoeckle , 2000 ] .\n",
      "['disease', 'illness', 'encephalitis', 'can', '[c]In', 'primary', 'infection', 'a', '[c]adults', '[p]severe']\n",
      "===========================\n",
      "1 6\n",
      "Infection with MV typically results in an acute febrile illness and rash due to viral replication first in mono-and lymphocytic cells , and then in a variety of tissues ( Katz 1995 ) .\n",
      "['[c]Infection', 'MV', 'viral', '[c]with', 'replication', '[p]typically', '(', 'to', 'acute', '1995']\n",
      "===========================\n",
      "1 6\n",
      "Infection with MV typically results in an acute febrile illness and rash due to viral replication first in mono-and lymphocytic cells , and then in a variety of tissues ( Katz 1995 ) .\n",
      "['Infection', 'febrile', 'acute', 'an', 'rash', '[p]illness', 'typically', '[p]MV', 'cells', 'and']\n",
      "===========================\n",
      "1 7\n",
      "BRV is a lytic infection and destruction of infected mucosal epithelial cells is an important component of disease pathogenesis .\n",
      "['[c]BRV', 'disease', 'is', 'mucosal', 'infection', 'infected', 'pathogenesis', 'epithelial', 'lytic', 'is']\n",
      "===========================\n",
      "1 7\n",
      "BRV is a lytic infection and destruction of infected mucosal epithelial cells is an important component of disease pathogenesis .\n",
      "['disease', '[p]mucosal', 'pathogenesis', 'is', 'epithelial', '[p]cells', 'BRV', '[p]is', 'destruction', 'of']\n",
      "===========================\n",
      "1 8\n",
      "FIV infection , in domestic cats , causes a variable immunodeficiency syndrome characterized by recurrent gingivitis-stomatitis , cachexia , wasting , neurology , and an increased incidence of tumor development [ 1 , 4 , 48 , 76 ] .\n",
      "['[c]infection', '[c]FIV', 'cats', 'domestic', 'a', 'in', 'syndrome', 'tumor', ',', 'recurrent']\n",
      "===========================\n",
      "1 8\n",
      "FIV infection , in domestic cats , causes a variable immunodeficiency syndrome characterized by recurrent gingivitis-stomatitis , cachexia , wasting , neurology , and an increased incidence of tumor development [ 1 , 4 , 48 , 76 ] .\n",
      "['syndrome', 'a', '[p]infection', '[p]recurrent', '[p]wasting', '[p]by', '[p]cats', 'neurology', '[c]domestic', '[c]tumor']\n",
      "===========================\n",
      "1 9\n",
      "Adenovirus infection can result in severe respiratory disease in lung transplant recipients , including rapidly progressive , necrotizing and potentially fatal pneumonia , as well as development of chronic lung disease with fibrosis and bronchiectasis ( Liu et al. 2010 ) .\n",
      "['[c]infection', '[c]Adenovirus', 'can', 'respiratory', 'pneumonia', 'disease', 'result', 'lung', 'severe', 'transplant']\n",
      "===========================\n",
      "1 9\n",
      "Adenovirus infection can result in severe respiratory disease in lung transplant recipients , including rapidly progressive , necrotizing and potentially fatal pneumonia , as well as development of chronic lung disease with fibrosis and bronchiectasis ( Liu et al. 2010 ) .\n",
      "['[p]disease', 'respiratory', 'can', 'pneumonia', '[c]infection', '[p]severe', 'in', 'development', '[c]Adenovirus', '[p]disease']\n",
      "===========================\n",
      "1 10\n",
      "Filovirusinduced disease begins with flu-like symptoms and progresses rapidly to the final stages of viral hemorrhagic fever infection , which are characterized by fever , hemorrhage , and hypotensive shock ( Groseth et al. , 2007 ; Zampieri et al. , 2007 ) .\n",
      "['disease', 'infection', 'viral', '[c]Filovirusinduced', 'fever', 'of', '(', '[c]with', 'shock', 'and']\n",
      "===========================\n",
      "1 10\n",
      "Filovirusinduced disease begins with flu-like symptoms and progresses rapidly to the final stages of viral hemorrhagic fever infection , which are characterized by fever , hemorrhage , and hypotensive shock ( Groseth et al. , 2007 ; Zampieri et al. , 2007 ) .\n",
      "['[c]disease', 'shock', 'infection', 'symptoms', 'hemorrhage', 'Filovirusinduced', '[c]with', '[p]of', 'fever', '(']\n",
      "===========================\n",
      "1 11\n",
      "PEDV infects the epithelium of the small intestine , an environment rich in proteases , and causes atrophy of the villi resulting in diarrhea and dehydration .\n",
      "['[c]PEDV', 'diarrhea', '[c]PEDV', 'intestine', 'epithelium', 'proteases', 'causes', 'infects', 'dehydration', 'atrophy']\n",
      "===========================\n",
      "1 11\n",
      "PEDV infects the epithelium of the small intestine , an environment rich in proteases , and causes atrophy of the villi resulting in diarrhea and dehydration .\n",
      "['diarrhea', 'atrophy', 'dehydration', '[c]PEDV', 'epithelium', 'intestine', 'the', '[p]proteases', 'causes', 'of']\n",
      "===========================\n",
      "1 12\n",
      "In humans , coronavirus infection results in respiratory tract complications with varying degree of severity and has been associated with gastroenteritis .\n",
      "['infection', 'coronavirus', ',', 'respiratory', 'gastroenteritis', '[c]In', '[c]humans', 'has', 'with', 'tract']\n",
      "===========================\n",
      "1 12\n",
      "In humans , coronavirus infection results in respiratory tract complications with varying degree of severity and has been associated with gastroenteritis .\n",
      "['gastroenteritis', 'complications', 'respiratory', '[p]infection', 'with', 'tract', 'severity', '[c]In', 'has', '[c]humans']\n",
      "===========================\n",
      "1 13\n",
      "Humans infected with RVFV usually develop an acute febrile myalgic syndrome ; however , a small percentage of patients have a lethal illness that results in hepatic damage , hemorrhagic fever-like illness , encephalitis and/or retinal vasculitis [ 8 ] .\n",
      "['[c]infected', 'RVFV', 'Humans', 'patients', 'with', 'illness', '[', 'have', 'of', 'acute']\n",
      "===========================\n",
      "1 13\n",
      "Humans infected with RVFV usually develop an acute febrile myalgic syndrome ; however , a small percentage of patients have a lethal illness that results in hepatic damage , hemorrhagic fever-like illness , encephalitis and/or retinal vasculitis [ 8 ] .\n",
      "['[c]syndrome', '[c]illness', 'patients', 'illness', '[c]Humans', '[p]damage', '[c]acute', '[p]febrile', '[c]an', '[c]encephalitis']\n",
      "===========================\n",
      "1 14\n",
      "PRRSV increases the susceptibility of the host to a wide range of viral and bacterial respiratory pathogens , resulting in increased severity of clinical signs and lung lesions .\n",
      "['[c]PRRSV', 'respiratory', 'increases', 'host', 'lung', 'clinical', 'pathogens', 'viral', 'severity', 'of']\n",
      "===========================\n",
      "1 14\n",
      "PRRSV increases the susceptibility of the host to a wide range of viral and bacterial respiratory pathogens , resulting in increased severity of clinical signs and lung lesions .\n",
      "['[p]severity', '[p]clinical', '[c]increases', 'lesions', 'lung', '[p]respiratory', '[p]of', '[p]host', '[p]increased', '[p]signs']\n",
      "===========================\n",
      "1 15\n",
      "In humans , the virus causes a lower respiratory tract disease and may progress to ARDS , multiorgan failure , and death in severe cases .\n",
      "['virus', 'the', 'a', '[c]In', 'humans', 'disease', 'respiratory', 'may', 'and', 'severe']\n",
      "===========================\n",
      "1 15\n",
      "In humans , the virus causes a lower respiratory tract disease and may progress to ARDS , multiorgan failure , and death in severe cases .\n",
      "['disease', 'virus', '[c]a', 'may', '[c]In', 'respiratory', 'ARDS', 'severe', 'humans', '[c]cases']\n",
      "===========================\n",
      "1 16\n",
      "In most cases , MERS-CoV causes severe infection in the lower respiratory tract in humans .\n",
      "['MERS-CoV', 'infection', 'severe', 'causes', ',', 'humans', 'most', 'cases', 'respiratory', '[c]In']\n",
      "===========================\n",
      "1 16\n",
      "In most cases , MERS-CoV causes severe infection in the lower respiratory tract in humans .\n",
      "['[c]infection', 'severe', 'humans', 'in', 'MERS-CoV', 'causes', 'in', '[c]respiratory', 'cases', '[p]most']\n",
      "===========================\n",
      "1 17\n",
      "In humans , SARS-CoV causes interstitial pneumonia with fever and sometimes diarrhea ( 3 , 4 ) .\n",
      "['SARS-CoV', 'pneumonia', 'interstitial', ',', '[c]In', 'diarrhea', 'causes', 'humans', '(', 'fever']\n",
      "===========================\n",
      "1 17\n",
      "In humans , SARS-CoV causes interstitial pneumonia with fever and sometimes diarrhea ( 3 , 4 ) .\n",
      "['pneumonia', 'diarrhea', '[p]interstitial', 'fever', '[c]In', 'with', '[c]humans', 'causes', '(', 'and']\n",
      "===========================\n",
      "1 18\n",
      "Infection of humans is characterized by a rapid and extensive spread of the virus in several organs with symptoms including respiratory distress and encephalitis ( 46 ) .\n",
      "['virus', 'Infection', 'is', 'humans', 'spread', 'encephalitis', '[c]of', 'of', 'a', 'by']\n",
      "===========================\n",
      "1 18\n",
      "Infection of humans is characterized by a rapid and extensive spread of the virus in several organs with symptoms including respiratory distress and encephalitis ( 46 ) .\n",
      "['is', 'encephalitis', 'Infection', 'humans', 'spread', 'virus', 'organs', 'respiratory', 'distress', 'symptoms']\n",
      "===========================\n",
      "1 19\n",
      "The HPeV-1 infection is mostly represented by a mild respiratory or gastrointestinal infection, but sometimes becomes clinically severe , leading to sepsis-like illness and central nervous system infection in infants .\n",
      "['[p]infection', '[c]HPeV-1', '[p]The', '[p]The', '[p]is', 'infection', 'gastrointestinal', 'infants', '[p]The', 'and']\n",
      "===========================\n",
      "1 19\n",
      "The HPeV-1 infection is mostly represented by a mild respiratory or gastrointestinal infection, but sometimes becomes clinically severe , leading to sepsis-like illness and central nervous system infection in infants .\n",
      "['[c]infection', '[c]is', 'infection', 'illness', 'gastrointestinal', '[c]infants', 'The', 'and', 'in', '[p]to']\n",
      "===========================\n",
      "1 20\n",
      "The pathogenesis of Ebola virus disease ( EVD ) is not well understood , but likely results from overwhelming cytopathic damage due to the ability of Ebola virus to replicate throughout many different tissues of the body , dysregulation of the immune response , and profound hypovolemia [ 9 ] .\n",
      "['virus', '[p]disease', 'virus', '[c]of', 'body', '(', '[p]of', '[c]EVD', 'is', 'overwhelming']\n",
      "===========================\n",
      "1 20\n",
      "The pathogenesis of Ebola virus disease ( EVD ) is not well understood , but likely results from overwhelming cytopathic damage due to the ability of Ebola virus to replicate throughout many different tissues of the body , dysregulation of the immune response , and profound hypovolemia [ 9 ] .\n",
      "['damage', 'body', 'disease', 'hypovolemia', '[p]overwhelming', 'is', '[p]overwhelming', 'profound', 'of', '[p]EVD']\n",
      "===========================\n",
      "1 21\n",
      "Currently , humans infected with MERS-CoV have been reported to develop a severe acute respiratory illness with symptoms of fever , cough , shortness of breath , and often , renal failure .\n",
      "['MERS-CoV', 'respiratory', 'infected', 'humans', '[c]Currently', 'have', 'illness', 'with', 'acute', 'with']\n",
      "===========================\n",
      "1 21\n",
      "Currently , humans infected with MERS-CoV have been reported to develop a severe acute respiratory illness with symptoms of fever , cough , shortness of breath , and often , renal failure .\n",
      "['illness', '[c]respiratory', 'humans', 'severe', 'have', '[c]Currently', '[c]a', '[c]acute', 'with', '[c]been']\n",
      "===========================\n",
      "1 22\n",
      "As discussed above , coxsackievirus B3 ( CVB3 ) infection causes myocarditis in human beings as well as in male BALB/c mice .\n",
      "['infection', 'coxsackievirus', '[p]causes', '(', '[p]causes', '[c]myocarditis', '[c]As', 'B3', 'human', 'in']\n",
      "===========================\n",
      "1 22\n",
      "As discussed above , coxsackievirus B3 ( CVB3 ) infection causes myocarditis in human beings as well as in male BALB/c mice .\n",
      "['myocarditis', 'causes', 'infection', 'causes', 'in', '[c]As', 'human', 'male', 'in', '(']\n",
      "===========================\n",
      "1 23\n",
      "PEDV infections cause acute , severe atrophic enteritis accompanied by viremia that leads to profound diarrhea and vomiting, followed by extensive dehydration , which is the major cause of death in nursing piglets .\n",
      "['[c]PEDV', '[c]infections', 'nursing', 'enteritis', 'that', 'piglets', 'by', 'nursing', 'acute', 'extensive']\n",
      "===========================\n",
      "1 23\n",
      "PEDV infections cause acute , severe atrophic enteritis accompanied by viremia that leads to profound diarrhea and vomiting, followed by extensive dehydration , which is the major cause of death in nursing piglets .\n",
      "['enteritis', 'dehydration', 'diarrhea', 'extensive', '[p]severe', 'profound', 'that', '[c]infections', '[c]and', '[c]death']\n",
      "===========================\n",
      "1 24\n",
      "During infection , JEV invades the central nervous system , wherein virus replication triggers a massive inflammatory response , and subsequently causes neuronal cell death ( 5 ) .\n",
      "['JEV', 'virus', 'infection', ',', 'replication', '[c]During', '[c]neuronal', 'nervous', 'central', 'inflammatory']\n",
      "===========================\n",
      "1 24\n",
      "During infection , JEV invades the central nervous system , wherein virus replication triggers a massive inflammatory response , and subsequently causes neuronal cell death ( 5 ) .\n",
      "['inflammatory', 'neuronal', '[c]nervous', '[p]central', 'death', '[c]infection', 'massive', 'response', '[p]replication', 'cell']\n",
      "===========================\n",
      "1 25\n",
      "Primary HHV-6 infection causes undifferentiated febrile illness and exanthem subitum ( roseola infantum or sixth disease ) , an acute illness with high fever and rash that typically resolves in three to seven days [ 49 ] .\n",
      "['infection', '[c]Primary', 'disease', 'causes', '[c]HHV-6', 'illness', '(', 'illness', '[c]Primary', 'and']\n",
      "===========================\n",
      "1 25\n",
      "Primary HHV-6 infection causes undifferentiated febrile illness and exanthem subitum ( roseola infantum or sixth disease ) , an acute illness with high fever and rash that typically resolves in three to seven days [ 49 ] .\n",
      "['[p]illness', '[p]illness', 'infection', 'disease', '[c]febrile', '[c]rash', 'and', '[c]Primary', '[c]causes', '[c](']\n",
      "===========================\n",
      "2 0\n",
      "After an incubation period of 5 to 14 days , SARS-CoV-2-infected people commonly manifest features of pneumonia , including fever , dry cough , dyspnoea , myalgia and fatigue .\n",
      "['people', 'SARS-CoV-2-infected', 'pneumonia', '[c]After', 'commonly', '[c]an', ',', 'fatigue', 'of', 'features']\n",
      "===========================\n",
      "2 0\n",
      "After an incubation period of 5 to 14 days , SARS-CoV-2-infected people commonly manifest features of pneumonia , including fever , dry cough , dyspnoea , myalgia and fatigue .\n",
      "['[c]pneumonia', '[p]fatigue', '[p]people', 'of', '[p]cough', '[c]After', 'SARS-CoV-2-infected', 'fever', 'commonly', 'features']\n",
      "===========================\n",
      "2 1\n",
      "After an incubation period of 2 to 3 days , patients who have pneumonic plague typically develop fulminant pneumonia , with malaise , high fever , cough , hemoptysis , and septicemia with ecchymoses and extremity necrosis .\n",
      "['patients', 'who', '[c]After', 'have', 'pneumonia', 'typically', 'develop', '[p]an', 'necrosis', 'plague']\n",
      "===========================\n",
      "2 1\n",
      "After an incubation period of 2 to 3 days , patients who have pneumonic plague typically develop fulminant pneumonia , with malaise , high fever , cough , hemoptysis , and septicemia with ecchymoses and extremity necrosis .\n",
      "['pneumonia', '[p]patients', 'have', 'necrosis', 'develop', 'develop', '[p]fulminant', '[c]septicemia', '[c]After', '[p]with']\n",
      "===========================\n",
      "2 2\n",
      "Patients suffering from severe DENV infection often exhibit encephalopathy and encephalitis .\n",
      "['[c]Patients', '[c]infection', 'severe', 'exhibit', '[p]often', 'DENV', '[p]from', 'encephalitis', '[c]suffering', 'severe']\n",
      "===========================\n",
      "2 2\n",
      "Patients suffering from severe DENV infection often exhibit encephalopathy and encephalitis .\n",
      "['encephalitis', 'severe', 'encephalopathy', '[p]infection', '[c]Patients', 'and', 'exhibit', 'DENV', '[c]from', 'often']\n",
      "===========================\n",
      "2 3\n",
      "Following an incubation period of usually 4 - 5 days , patients infected with SARS-CoV often present with symptoms of fever , headache , and myalgias .\n",
      "['patients', 'infected', '[c]Following', 'often', 'present', 'symptoms', 'with', '[p]an', 'SARS-CoV', 'fever']\n",
      "===========================\n",
      "2 3\n",
      "Following an incubation period of usually 4 - 5 days , patients infected with SARS-CoV often present with symptoms of fever , headache , and myalgias .\n",
      "['patients', '[c]symptoms', 'fever', 'headache', 'present', 'Following', 'infected', 'with', 'and', '[p]of']\n",
      "===========================\n",
      "2 4\n",
      "Cats with FIP show nonspecific clinical signs such as fever , weight loss and anorexia , often accompanied by body cavity effusions and/or ocular and neurological signs .\n",
      "['[c]Cats', 'show', 'with', 'nonspecific', '[c]clinical', '[p]FIP', 'with', '[p]signs', 'fever', 'such']\n",
      "===========================\n",
      "2 4\n",
      "Cats with FIP show nonspecific clinical signs such as fever , weight loss and anorexia , often accompanied by body cavity effusions and/or ocular and neurological signs .\n",
      "['clinical', 'nonspecific', 'fever', 'show', '[c]Cats', '[c]FIP', '[p]signs', '[c]signs', '[p]by', '[c]with']\n",
      "===========================\n",
      "2 5\n",
      "Cats with signs from FIV often have lethargy , anorexia and weight loss associated with secondary infections of the skin , and gastrointestinal or respiratory tracts .\n",
      "['[c]Cats', '[p]with', '[p]often', 'have', '[c]FIV', 'from', 'infections', 'signs', 'associated', 'from']\n",
      "===========================\n",
      "2 5\n",
      "Cats with signs from FIV often have lethargy , anorexia and weight loss associated with secondary infections of the skin , and gastrointestinal or respiratory tracts .\n",
      "['have', 'have', 'FIV', 'with', '[c]secondary', 'Cats', '[p]associated', 'often', '[c]infections', 'from']\n",
      "===========================\n",
      "2 6\n",
      "Enteric FCoV infection typically results in inappetence and/or mild gastrointestinal signs such as vomiting and diarrhea .\n",
      "['infection', '[c]Enteric', '[c]results', 'typically', '[c]FCoV', 'in', 'mild', 'signs', 'vomiting', 'diarrhea']\n",
      "===========================\n",
      "2 6\n",
      "Enteric FCoV infection typically results in inappetence and/or mild gastrointestinal signs such as vomiting and diarrhea .\n",
      "['infection', 'Enteric', '[c]results', 'mild', '[p]diarrhea', '[p]vomiting', '[p]signs', 'gastrointestinal', '[p]typically', 'FCoV']\n",
      "===========================\n",
      "2 7\n",
      "Most patients with MERS develop severe acute respiratory illness accompanied by fever , cough , and shortness of breath [ 50 ] .\n",
      "['patients', '[c]Most', 'develop', 'with', 'respiratory', '[p]MERS', '[c]severe', '[', 'illness', 'acute']\n",
      "===========================\n",
      "2 7\n",
      "Most patients with MERS develop severe acute respiratory illness accompanied by fever , cough , and shortness of breath [ 50 ] .\n",
      "['respiratory', '[p]illness', '[c]severe', '[c]acute', 'develop', '[p]cough', '[p]fever', '[c]MERS', 'by', '[c]patients']\n",
      "===========================\n",
      "2 8\n",
      "The terminal stages of Ebola virus infection usually include diffuse bleeding , and hypotensive shock accounts for many Ebola virus fatalities .\n",
      "['infection', '[p]stages', 'of', '[c]usually', 'bleeding', 'shock', '[c]include', 'virus', '[c]terminal', 'diffuse']\n",
      "===========================\n",
      "2 8\n",
      "The terminal stages of Ebola virus infection usually include diffuse bleeding , and hypotensive shock accounts for many Ebola virus fatalities .\n",
      "['infection', 'bleeding', 'diffuse', 'shock', '[c]of', 'include', '[c]stages', '[c]terminal', 'virus', 'usually']\n",
      "===========================\n",
      "2 9\n",
      "In rats , infection is usually asymptomatic , although nonspecific clinical signs such as weight loss and dyspnea may occur .\n",
      "['infection', '[c]rats', 'In', 'is', 'dyspnea', 'clinical', 'nonspecific', 'asymptomatic', 'occur', 'weight']\n",
      "===========================\n",
      "2 9\n",
      "In rats , infection is usually asymptomatic , although nonspecific clinical signs such as weight loss and dyspnea may occur .\n",
      "['[c]clinical', 'infection', 'dyspnea', '[c]is', 'nonspecific', '[p]weight', '[c]In', 'and', 'signs', 'occur']\n",
      "===========================\n",
      "2 10\n",
      "Following an average incubation period of 20 days , infected patients can present with severe headache , fever , chills , fatigue , and myalgia .\n",
      "['patients', 'infected', 'can', 'present', '[c]Following', 'incubation', 'severe', 'days', 'headache', 'average']\n",
      "===========================\n",
      "2 10\n",
      "Following an average incubation period of 20 days , infected patients can present with severe headache , fever , chills , fatigue , and myalgia .\n",
      "['patients', 'severe', '[c]infected', 'can', '[c]headache', '[p]present', 'incubation', '[p]myalgia', 'fatigue', '[p]fever']\n",
      "===========================\n",
      "2 11\n",
      "Patients infected with EVD rapidly deteriorate and commonly present with gastrointestinal symptoms including vomiting , diarrhea and dehydration .\n",
      "['[c]Patients', '[p]infected', 'rapidly', '[c]EVD', '[p]and', 'rapidly', 'with', 'commonly', 'including', '[p]symptoms']\n",
      "===========================\n",
      "2 11\n",
      "Patients infected with EVD rapidly deteriorate and commonly present with gastrointestinal symptoms including vomiting , diarrhea and dehydration .\n",
      "['Patients', 'symptoms', 'dehydration', '[c]rapidly', 'vomiting', 'gastrointestinal', '[p]with', 'diarrhea', '[c]infected', 'including']\n",
      "===========================\n",
      "2 12\n",
      "Adult rabbits usually develop a chronic disease course , which can lead to intestinal fi brosis , liver necrosis and stenosis , and myocardial disease .\n",
      "['[c]rabbits', '[c]Adult', 'usually', 'develop', 'intestinal', 'disease', 'chronic', 'a', 'course', 'can']\n",
      "===========================\n",
      "2 12\n",
      "Adult rabbits usually develop a chronic disease course , which can lead to intestinal fi brosis , liver necrosis and stenosis , and myocardial disease .\n",
      "['disease', '[c]chronic', 'intestinal', '[p]disease', 'course', '[p]liver', '[c]develop', '[c]a', '[c]necrosis', '[c]rabbits']\n",
      "===========================\n",
      "2 13\n",
      "Cats are primarily infected subclinically , but gastrointestinal disease manifested as enterocolitis and endotoxemia can occur and is initially associated with fever , malaise , and anorexia followed by vomiting , abdominal pain , and diarrhoea [ 7 ] .\n",
      "['[c]Cats', 'infected', 'are', 'but', 'is', '[', 'subclinically', 'disease', 'primarily', '7']\n",
      "===========================\n",
      "2 13\n",
      "Cats are primarily infected subclinically , but gastrointestinal disease manifested as enterocolitis and endotoxemia can occur and is initially associated with fever , malaise , and anorexia followed by vomiting , abdominal pain , and diarrhoea [ 7 ] .\n",
      "['disease', 'infected', '[c]is', '[c]but', '[c]Cats', 'gastrointestinal', '[p]diarrhoea', 'are', '[p]associated', '[p]with']\n",
      "===========================\n",
      "2 14\n",
      "Affected rabbits usually develop sepsis , which quickly leads to death ; however , diarrhea may occur as well .\n",
      "['[c]rabbits', '[c]Affected', 'sepsis', 'diarrhea', 'usually', 'develop', ';', 'death', 'occur', 'may']\n",
      "===========================\n",
      "2 14\n",
      "Affected rabbits usually develop sepsis , which quickly leads to death ; however , diarrhea may occur as well .\n",
      "['sepsis', 'diarrhea', 'death', 'occur', '[c]rabbits', 'develop', '[c]Affected', 'may', ';', 'usually']\n",
      "===========================\n",
      "2 15\n",
      "Common marmosets with measles infection become clinically apparent with lethargy , facial edema , and nasal discharge and occasionally develop an exanthema .\n",
      "['[c]marmosets', '[c]infection', '[p]with', '[c]measles', '[c]Common', 'become', '[c]Common', 'an', '[c]and', '[c]clinically']\n",
      "===========================\n",
      "2 15\n",
      "Common marmosets with measles infection become clinically apparent with lethargy , facial edema , and nasal discharge and occasionally develop an exanthema .\n",
      "['infection', '[p]an', '[c]measles', 'nasal', 'with', 'become', 'discharge', '[c]clinically', 'with', 'facial']\n",
      "===========================\n",
      "2 16\n",
      "In humans , VEEV infection causes a sudden onset of malaise , fever , chills , headache , and sore throat .\n",
      "['humans', 'infection', '[c]In', 'sudden', 'onset', 'a', 'causes', 'VEEV', 'of', 'headache']\n",
      "===========================\n",
      "2 16\n",
      "In humans , VEEV infection causes a sudden onset of malaise , fever , chills , headache , and sore throat .\n",
      "['[c]sudden', '[c]infection', 'onset', 'a', '[c]headache', '[p]of', '[p]In', '[c]fever', '[p]causes', '[p]and']\n",
      "===========================\n",
      "2 17\n",
      "Humans infected with RVFV usually develop an acute febrile myalgic syndrome ; however , a small percentage of patients have a lethal illness that results in hepatic damage , hemorrhagic fever-like illness , encephalitis and/or retinal vasculitis [ 8 ] .\n",
      "['[c]Humans', 'patients', 'infected', 'of', 'usually', 'develop', '[', ';', 'have', 'illness']\n",
      "===========================\n",
      "2 17\n",
      "Humans infected with RVFV usually develop an acute febrile myalgic syndrome ; however , a small percentage of patients have a lethal illness that results in hepatic damage , hemorrhagic fever-like illness , encephalitis and/or retinal vasculitis [ 8 ] .\n",
      "['syndrome', 'illness', '[c]illness', '[c]febrile', 'acute', 'patients', '[p]an', '[c]Humans', 'encephalitis', '[c]retinal']\n",
      "===========================\n",
      "2 18\n",
      "In humans , infection is associated with fever and liver damage , but a subset of patients progress to hemorrhagic fever , encephalitis , ocular disease or death .\n",
      "['patients', '[c]humans', 'infection', 'is', 'In', 'of', 'fever', 'but', 'liver', 'damage']\n",
      "===========================\n",
      "2 18\n",
      "In humans , infection is associated with fever and liver damage , but a subset of patients progress to hemorrhagic fever , encephalitis , ocular disease or death .\n",
      "['[c]infection', '[p]fever', '[c]liver', 'damage', '[p]fever', '[c]encephalitis', '[p]patients', 'disease', '[c]is', 'hemorrhagic']\n",
      "===========================\n",
      "2 19\n",
      "After an incubation period of 9 - 12 days , MERS generally presents in humans as a lower respiratory infection with fever ( often with chills or rigors ) , dry or productive cough and dyspnea .\n",
      "['humans', 'generally', '[c]After', 'infection', 'presents', 'in', 'MERS', 'an', 'incubation', 'dyspnea']\n",
      "===========================\n",
      "2 19\n",
      "After an incubation period of 9 - 12 days , MERS generally presents in humans as a lower respiratory infection with fever ( often with chills or rigors ) , dry or productive cough and dyspnea .\n",
      "['[c]infection', '[p]dyspnea', '[p]fever', '[p]cough', '[c]respiratory', 'MERS', 'humans', '[p]generally', '[p]a', '[c]After']\n",
      "===========================\n",
      "2 20\n",
      "Patients with bubonic plague usually develop symptoms of fever , headache , chills , and swollen , extremely tender lymph nodes ( buboes ) within 2 to 6 days after contact with the pathogen .\n",
      "['[c]Patients', 'usually', '[p]develop', 'with', 'symptoms', 'with', 'contact', 'pathogen', '[p]plague', 'days']\n",
      "===========================\n",
      "2 20\n",
      "Patients with bubonic plague usually develop symptoms of fever , headache , chills , and swollen , extremely tender lymph nodes ( buboes ) within 2 to 6 days after contact with the pathogen .\n",
      "['symptoms', '[p]Patients', 'develop', 'fever', '[c]lymph', '[p]pathogen', '[c]usually', 'headache', '[c]plague', '[c]of']\n",
      "===========================\n",
      "2 21\n",
      "Symptomatic CHIKV infection often manifests itself by short-lived fever and recurrent joint pain , which can last for months to years ( 10 ) .\n",
      "['infection', '[c]Symptomatic', 'often', 'which', '(', '[c]CHIKV', 'joint', '10', ')', 'fever']\n",
      "===========================\n",
      "2 21\n",
      "Symptomatic CHIKV infection often manifests itself by short-lived fever and recurrent joint pain , which can last for months to years ( 10 ) .\n",
      "['[c]infection', 'Symptomatic', 'fever', 'joint', 'pain', 'recurrent', 'and', 'which', '[p]by', '[c]often']\n",
      "===========================\n",
      "2 22\n",
      "Pneumonia caused by SARS-CoV typically has an insidious onset , and respiratory symptoms worsen slowly but steadily during the first 10 to 15 days [ 10 ] .\n",
      "['[c]Pneumonia', 'respiratory', 'symptoms', 'typically', '[c]and', '[', 'by', 'by', 'caused', 'has']\n",
      "===========================\n",
      "2 22\n",
      "Pneumonia caused by SARS-CoV typically has an insidious onset , and respiratory symptoms worsen slowly but steadily during the first 10 to 15 days [ 10 ] .\n",
      "['Pneumonia', 'respiratory', 'symptoms', 'typically', '[c]and', 'onset', '[c]by', 'has', '[c]caused', '[c]by']\n",
      "===========================\n",
      "2 23\n",
      "Those infected with SARS suffer fever , cough , muscle aches , and shortness of breath and often progress to severe lung inflammation .\n",
      "['[c]Those', '[c]infected', '[p]with', 'lung', 'severe', 'suffer', 'fever', 'SARS', 'inflammation', '[c]cough']\n",
      "===========================\n",
      "2 23\n",
      "Those infected with SARS suffer fever , cough , muscle aches , and shortness of breath and often progress to severe lung inflammation .\n",
      "['[c]lung', '[c]severe', '[c]inflammation', 'fever', 'cough', '[p]with', '[p]Those', '[c]suffer', 'to', '[c]SARS']\n",
      "===========================\n",
      "4 0\n",
      "Patients with lung cancer are highly susceptible to infection compared to healthy individuals because of systemic immunosuppression induced by malignancy and anticancer therapy .\n",
      "['cancer', 'infection', '[c]lung', '[c]Patients', 'are', 'therapy', 'malignancy', 'systemic', 'systemic', 'and']\n",
      "===========================\n",
      "4 0\n",
      "Patients with lung cancer are highly susceptible to infection compared to healthy individuals because of systemic immunosuppression induced by malignancy and anticancer therapy .\n",
      "['infection', 'are', '[c]Patients', 'cancer', 'systemic', 'lung', 'malignancy', 'to', 'of', 'systemic']\n",
      "===========================\n",
      "4 1\n",
      "Patients with lung cancer are highly susceptible to infection compared to healthy individuals because of systemic immunosuppression induced by malignancy and anticancer therapy .\n",
      "['cancer', 'infection', '[c]lung', '[c]Patients', 'are', 'therapy', 'malignancy', 'systemic', 'systemic', 'and']\n",
      "===========================\n",
      "4 1\n",
      "Patients with lung cancer are highly susceptible to infection compared to healthy individuals because of systemic immunosuppression induced by malignancy and anticancer therapy .\n",
      "['infection', 'are', '[c]Patients', 'cancer', 'systemic', 'lung', 'malignancy', 'to', 'of', 'systemic']\n",
      "===========================\n",
      "4 2\n",
      "Patients with ARDS triggered by viral infection , in particular influenza , are prone to invasive aspergillosis even in absence of prior immunodeficiency .\n",
      "['ARDS', '[c]Patients', 'influenza', 'are', 'immunodeficiency', 'prior', 'with', 'with', 'infection', 'viral']\n",
      "===========================\n",
      "4 2\n",
      "Patients with ARDS triggered by viral infection , in particular influenza , are prone to invasive aspergillosis even in absence of prior immunodeficiency .\n",
      "['[p]infection', 'Patients', '[p]invasive', 'influenza', 'are', '[p]invasive', 'aspergillosis', '[p]ARDS', 'prior', 'to']\n",
      "===========================\n",
      "4 3\n",
      "Individuals with SCD are strongly susceptible to encapsulated bacterial organisms such as S. pneumoniae , a common colonizer of the nasopharynx in healthy children .\n",
      "['SCD', 'are', 'children', 'with', '[c]Individuals', 'healthy', 'strongly', 'in', 'bacterial', 'such']\n",
      "===========================\n",
      "4 3\n",
      "Individuals with SCD are strongly susceptible to encapsulated bacterial organisms such as S. pneumoniae , a common colonizer of the nasopharynx in healthy children .\n",
      "['organisms', 'bacterial', 'are', 'SCD', 'to', 'encapsulated', 'children', '[c]Individuals', 'in', 'strongly']\n",
      "===========================\n",
      "4 4\n",
      "Individuals with diabetes , immunosuppressive disorders , and liver disease including hemochromatosis and alcoholic liver disease are especially susceptible to infection .\n",
      "['diabetes', 'infection', '[c]are', '[c]disease', 'and', '[c]disease', '[p]hemochromatosis', '[c]Individuals', 'with', '[c]disorders']\n",
      "===========================\n",
      "4 4\n",
      "Individuals with diabetes , immunosuppressive disorders , and liver disease including hemochromatosis and alcoholic liver disease are especially susceptible to infection .\n",
      "['infection', 'are', 'to', '[p]Individuals', 'and', 'especially', 'diabetes', 'susceptible', 'including', 'and']\n",
      "===========================\n",
      "4 5\n",
      "Moreover , children receiving immunomodulatory or immunosuppressive therapies due to malignancy , transplantation , or autoimmune disease are more susceptible to viral infection or reactivation .\n",
      "['children', 'disease', '[p]are', 'Moreover', 'viral', 'malignancy', '[c]reactivation', '[c]autoimmune', 'receiving', '[c]therapies']\n",
      "===========================\n",
      "4 5\n",
      "Moreover , children receiving immunomodulatory or immunosuppressive therapies due to malignancy , transplantation , or autoimmune disease are more susceptible to viral infection or reactivation .\n",
      "['infection', 'viral', 'reactivation', '[c]children', 'or', 'are', '[c]Moreover', 'to', 'disease', 'more']\n",
      "===========================\n",
      "4 6\n",
      "Accordingly , young children , compared with adult transplant recipients , are at higher risk of acquiring primary infection with many organisms after they are immunosuppressed , which can lead to increased severity .\n",
      "['infection', 'transplant', '[c]children', 'recipients', 'severity', 'are', 'primary', 'immunosuppressed', 'after', 'they']\n",
      "===========================\n",
      "4 6\n",
      "Accordingly , young children , compared with adult transplant recipients , are at higher risk of acquiring primary infection with many organisms after they are immunosuppressed , which can lead to increased severity .\n",
      "['infection', 'primary', 'organisms', 'severity', 'acquiring', 'many', 'children', 'increased', 'with', '[p]transplant']\n",
      "===========================\n",
      "4 7\n",
      "On one hand , elderly patients are at risk for gram-negative and anaerobic polymicrobial aspiration pneumonia , and on the other hand are more prone to bacterial superinfections following influenza infection .\n",
      "['patients', 'pneumonia', 'infection', '[c]elderly', 'influenza', 'are', 'bacterial', 'are', 'and', 'superinfections']\n",
      "===========================\n",
      "4 7\n",
      "On one hand , elderly patients are at risk for gram-negative and anaerobic polymicrobial aspiration pneumonia , and on the other hand are more prone to bacterial superinfections following influenza infection .\n",
      "['[c]infection', 'pneumonia', '[c]bacterial', 'influenza', '[c]patients', 'superinfections', 'following', 'aspiration', '[c]bacterial', 'elderly']\n",
      "===========================\n",
      "4 8\n",
      "Patients with cancer are known to be at an increased risk for community-acquired respiratory viruses , such as influenza , because of their frequently observed immunocompromised state .\n",
      "['cancer', '[c]Patients', 'are', 'influenza', 'observed', 'state', 'known', 'with', 'their', 'viruses']\n",
      "===========================\n",
      "4 8\n",
      "Patients with cancer are known to be at an increased risk for community-acquired respiratory viruses , such as influenza , because of their frequently observed immunocompromised state .\n",
      "['influenza', 'viruses', 'cancer', '[c]Patients', 'respiratory', 'are', 'observed', 'risk', 'be', '[c]known']\n",
      "===========================\n",
      "4 9\n",
      "However , immunocompromised patients , including those with HIV/AIDS and patients taking immunosuppressants post-transplant , are at an increased risk for viral and fungal pneumonia .\n",
      "['patients', '[c]pneumonia', '[c]However', 'are', '[p]post-transplant', ',', 'patients', '[c]and', '[c]HIV/AIDS', 'immunocompromised']\n",
      "===========================\n",
      "4 9\n",
      "However , immunocompromised patients , including those with HIV/AIDS and patients taking immunosuppressants post-transplant , are at an increased risk for viral and fungal pneumonia .\n",
      "['pneumonia', '[c]patients', '[c]However', 'viral', 'are', 'fungal', 'and', 'risk', 'for', 'post-transplant']\n",
      "===========================\n",
      "4 10\n",
      "Although the incidence of RSV infection is low among patients with AML , it is associated with high mortality in children with AML [ 21 ] , and it is well known that infants , both immunocompetent and immunocompromised , are particularly vulnerable to RSV .\n",
      "['AML', 'AML', 'infection', 'RSV', 'RSV', '[p]are', '[c]patients', 'mortality', '[p]children', 'infants']\n",
      "===========================\n",
      "4 10\n",
      "Although the incidence of RSV infection is low among patients with AML , it is associated with high mortality in children with AML [ 21 ] , and it is well known that infants , both immunocompetent and immunocompromised , are particularly vulnerable to RSV .\n",
      "['infection', 'RSV', 'RSV', 'mortality', 'infants', 'AML', '[c]of', 'are', 'to', 'AML']\n",
      "===========================\n",
      "4 11\n",
      "However , neonates , older individuals , and those with immune deficiencies are prone to more frequent and more serious CNS viral infections .\n",
      "['However', '[p]infections', 'are', '[p]immune', 'individuals', 'viral', 'neonates', '[p]deficiencies', '[c]and', '[p]those']\n",
      "===========================\n",
      "4 11\n",
      "However , neonates , older individuals , and those with immune deficiencies are prone to more frequent and more serious CNS viral infections .\n",
      "['infections', 'viral', '[c]However', 'are', 'CNS', 'neonates', 'immune', 'individuals', 'to', 'and']\n",
      "===========================\n",
      "4 12\n",
      "However , immunocompromised individuals , both children and adults , are prone to develop severe illness as a result of HPIV infection .\n",
      "['illness', 'infection', 'However', '[c]are', 'individuals', 'severe', '[c],', 'of', 'develop', 'immunocompromised']\n",
      "===========================\n",
      "4 12\n",
      "However , immunocompromised individuals , both children and adults , are prone to develop severe illness as a result of HPIV infection .\n",
      "['infection', 'illness', 'However', 'are', 'severe', 'develop', 'of', 'HPIV', 'individuals', '[c],']\n",
      "===========================\n",
      "4 13\n",
      "Due to the physiological changes in their immune and cardiopulmonary systems , pregnant women are more likely to develop severe illness after infection with respiratory viruses .\n",
      "['illness', 'pregnant', 'viruses', 'women', 'are', 'their', 'severe', 'after', 'infection', '[c]physiological']\n",
      "===========================\n",
      "4 13\n",
      "Due to the physiological changes in their immune and cardiopulmonary systems , pregnant women are more likely to develop severe illness after infection with respiratory viruses .\n",
      "['illness', 'infection', 'viruses', 'after', 'severe', 'respiratory', 'develop', 'are', 'pregnant', 'physiological']\n",
      "===========================\n",
      "4 14\n",
      "The patients with rheumatic immune diseases have immune dysfunction and are often on glucocorticoid and immunosuppressant therapy , which in turn predispose them to an increased risk of contracting SARS-CoV-2 infection .\n",
      "['diseases', 'patients', 'immune', 'have', '[c]The', 'dysfunction', 'infection', 'with', 'therapy', 'immune']\n",
      "===========================\n",
      "4 14\n",
      "The patients with rheumatic immune diseases have immune dysfunction and are often on glucocorticoid and immunosuppressant therapy , which in turn predispose them to an increased risk of contracting SARS-CoV-2 infection .\n",
      "['infection', 'immune', '[p]contracting', '[c]The', '[p]have', 'patients', '[p]contracting', '[p]them', 'risk', 'diseases']\n",
      "===========================\n",
      "4 15\n",
      "Although most infected patients have mild to moderate symptoms or are even asymptomatic , older patients or those with existing chronic diseases are at greater risk of developing serious complications such as pneumonia or multiple organ failures .\n",
      "['[c]patients', '[c]infected', 'diseases', '[c]patients', 'symptoms', '[p]chronic', 'pneumonia', 'complications', 'are', 'most']\n",
      "===========================\n",
      "4 15\n",
      "Although most infected patients have mild to moderate symptoms or are even asymptomatic , older patients or those with existing chronic diseases are at greater risk of developing serious complications such as pneumonia or multiple organ failures .\n",
      "['pneumonia', 'infected', '[c]patients', 'complications', '[c]symptoms', 'patients', 'or', '[c]are', 'serious', 'diseases']\n",
      "===========================\n",
      "4 16\n",
      "Among patients , those with cystic fibrosis ( CF ) , chronic obstructive pulmonary disease ( COPD ) , and on mechanical ventilation are particularly prone to develop pneumonia caused by PA infection [ 6 ] .\n",
      "['CF', '[p]pneumonia', 'patients', '[p]infection', '[p]are', 'ventilation', 'COPD', '[c]Among', '[c][', 'with']\n",
      "===========================\n",
      "4 16\n",
      "Among patients , those with cystic fibrosis ( CF ) , chronic obstructive pulmonary disease ( COPD ) , and on mechanical ventilation are particularly prone to develop pneumonia caused by PA infection [ 6 ] .\n",
      "['infection', 'pneumonia', 'by', 'develop', '[c]patients', 'PA', 'are', '[', '[c]Among', 'caused']\n",
      "===========================\n",
      "4 17\n",
      "Cancer patients , particularly those under anticancer treatment , are potentially more susceptible for a severe infection .\n",
      "['[c]Cancer', '[c]patients', 'infection', 'treatment', 'are', 'severe', '[c]anticancer', 'a', 'potentially', 'those']\n",
      "===========================\n",
      "4 17\n",
      "Cancer patients , particularly those under anticancer treatment , are potentially more susceptible for a severe infection .\n",
      "['infection', 'severe', '[c]patients', 'a', '[c]Cancer', 'are', 'treatment', 'potentially', 'susceptible', 'for']\n",
      "===========================\n",
      "4 18\n",
      "Affected individuals are immunosuppressed , and therefore , are more susceptible to influenza , viral enteritis , and distemper [ 1 , 26 ] .\n",
      "['[p]individuals', 'are', 'influenza', '[p]Affected', 'are', '[', 'are', '[p]immunosuppressed', 'enteritis', '26']\n",
      "===========================\n",
      "4 18\n",
      "Affected individuals are immunosuppressed , and therefore , are more susceptible to influenza , viral enteritis , and distemper [ 1 , 26 ] .\n",
      "['[c]influenza', 'individuals', 'are', '[c]Affected', 'enteritis', '[', 'are', 'to', 'are', '[p]and']\n",
      "===========================\n",
      "4 19\n",
      "Preterm infants , especially very low birth weight infants , have low immune function , which is the main risk group of neonatal fungal infection .\n",
      "['infection', 'have', 'infants', 'Preterm', '[c]immune', 'fungal', 'infants', 'neonatal', 'low', 'function']\n",
      "===========================\n",
      "4 19\n",
      "Preterm infants , especially very low birth weight infants , have low immune function , which is the main risk group of neonatal fungal infection .\n",
      "['infection', 'fungal', 'neonatal', '[c]infants', 'immune', 'of', 'have', '[c]Preterm', 'infants', 'risk']\n",
      "===========================\n",
      "4 20\n",
      "Patients with cancer are more susceptible to the infection owing to their immunocompromised state .\n",
      "['cancer', '[c]Patients', 'infection', 'are', 'their', 'with', 'state', 'their', 'their', 'the']\n",
      "===========================\n",
      "4 20\n",
      "Patients with cancer are more susceptible to the infection owing to their immunocompromised state .\n",
      "['infection', '[c]Patients', 'the', '[p]cancer', 'are', 'their', 'to', 'susceptible', 'their', 'more']\n",
      "===========================\n",
      "4 21\n",
      "Individuals with underlying medical conditions are at increased risk of pneumonia , which may be due to viral extension to the lungs or bacterial superinfection .\n",
      "['pneumonia', '[c]conditions', 'Individuals', '[p]are', 'underlying', 'medical', '[c]with', 'or', 'lungs', 'viral']\n",
      "===========================\n",
      "4 21\n",
      "Individuals with underlying medical conditions are at increased risk of pneumonia , which may be due to viral extension to the lungs or bacterial superinfection .\n",
      "['pneumonia', 'superinfection', 'viral', 'bacterial', 'lungs', 'are', '[c]Individuals', 'or', 'which', 'to']\n",
      "===========================\n",
      "4 22\n",
      "Patients with immunodeficiency due to human immunodeficiency virus ( HIV ) infection are highly susceptible to viral sepsis depending on the stage of disease and access and response to the treatment ( 19 ) .\n",
      "['Patients', 'disease', '[c]immunodeficiency', 'infection', '[p]are', 'HIV', 'treatment', 'with', 'sepsis', 'viral']\n",
      "===========================\n",
      "4 22\n",
      "Patients with immunodeficiency due to human immunodeficiency virus ( HIV ) infection are highly susceptible to viral sepsis depending on the stage of disease and access and response to the treatment ( 19 ) .\n",
      "['sepsis', 'viral', 'infection', '[c]Patients', 'are', 'treatment', 'to', 'HIV', 'disease', '[c]with']\n",
      "===========================\n",
      "4 23\n",
      "Elderly patients are also more prone to RSV infections due to their decreased immunologic response to the virus [ 13 ] .\n",
      "['[c]patients', '[c]Elderly', 'infections', 'are', 'RSV', 'virus', '[', 'their', 'decreased', 'decreased']\n",
      "===========================\n",
      "4 23\n",
      "Elderly patients are also more prone to RSV infections due to their decreased immunologic response to the virus [ 13 ] .\n",
      "['infections', 'RSV', 'virus', '[c]patients', 'decreased', 'are', '[', 'to', '[c]Elderly', 'their']\n",
      "===========================\n",
      "4 24\n",
      "Patients with DS are highly susceptible to lower and higher respiratory tract infection .\n",
      "['DS', '[c]Patients', 'are', 'infection', 'with', 'respiratory', 'highly', 'to', 'susceptible', 'and']\n",
      "===========================\n",
      "4 24\n",
      "Patients with DS are highly susceptible to lower and higher respiratory tract infection .\n",
      "['[p]infection', '[p]Patients', '[c]are', 'respiratory', '[c]to', 'DS', '[p]tract', 'susceptible', '[p]and', 'highly']\n",
      "===========================\n",
      "5 0\n",
      "However , while tocilizumab is a promising agent against COVID-19 , it is not an appropriate agent in patients with active or latent tuberculosis , bacterial and fungal infections , multi-organ failure , and gastrointestinal perforation [ 7 ] .\n",
      "['it', 'agent', 'agent', '[c]tocilizumab', '[', 'patients', 'is', 'tuberculosis', 'is', 'in']\n",
      "===========================\n",
      "5 0\n",
      "However , while tocilizumab is a promising agent against COVID-19 , it is not an appropriate agent in patients with active or latent tuberculosis , bacterial and fungal infections , multi-organ failure , and gastrointestinal perforation [ 7 ] .\n",
      "['[p]tuberculosis', 'patients', '[c]However', '[', 'against', '[p]with', '[c]and', '[c]active', 'it', 'is']\n",
      "===========================\n",
      "5 1\n",
      "There are cases of ADEM or even fulminant presentation such as AHL where steroids alone are not sufficient for suppressing inflammation and improving clinical findings .\n",
      "['steroids', 'alone', 'inflammation', 'are', 'clinical', '[c]There', 'not', 'even', 'sufficient', 'or']\n",
      "===========================\n",
      "5 1\n",
      "There are cases of ADEM or even fulminant presentation such as AHL where steroids alone are not sufficient for suppressing inflammation and improving clinical findings .\n",
      "['[c]inflammation', 'clinical', 'steroids', 'AHL', '[c]There', 'findings', '[c]or', 'presentation', 'of', 'ADEM']\n",
      "===========================\n",
      "5 2\n",
      "Thus , ribavirin may not be useful for treating SARS infections because of its questionable efficacy and because of its known toxicity ( reviewed by van Vonderen et al. , 2003 ; Lai , 2005 ) .\n",
      "['ribavirin', ',', 'infections', 'treating', ',', '(', '[c]Thus', 'treating', 'efficacy', 'may']\n",
      "===========================\n",
      "5 2\n",
      "Thus , ribavirin may not be useful for treating SARS infections because of its questionable efficacy and because of its known toxicity ( reviewed by van Vonderen et al. , 2003 ; Lai , 2005 ) .\n",
      "['SARS', 'infections', 'treating', 'treating', '(', '[c]Thus', ')', 'for', '[c],', 'efficacy']\n",
      "===========================\n",
      "5 3\n",
      "In general , steroid therapy is not recommended in the clinical treatment of SARS-CoV-2 [ 103 ] .\n",
      "['therapy', 'steroid', 'is', 'clinical', 'treatment', '[', ']', 'not', 'in', 'of']\n",
      "===========================\n",
      "5 3\n",
      "In general , steroid therapy is not recommended in the clinical treatment of SARS-CoV-2 [ 103 ] .\n",
      "['of', 'treatment', 'of', 'of', 'clinical', 'steroid', 'is', 'therapy', '[', 'SARS-CoV-2']\n",
      "===========================\n",
      "5 4\n",
      "In fact , steroids are not recommended in COVID-19 infection outside of clinical trial because of potential increased risk of mechanical ventilation ( 10 ) .\n",
      "['steroids', 'ventilation', 'are', 'clinical', 'infection', 'mechanical', ')', '(', 'trial', '10']\n",
      "===========================\n",
      "5 4\n",
      "In fact , steroids are not recommended in COVID-19 infection outside of clinical trial because of potential increased risk of mechanical ventilation ( 10 ) .\n",
      "['infection', 'clinical', 'steroids', 'in', 'ventilation', 'in', '10', 'in', '(', 'increased']\n",
      "===========================\n",
      "5 5\n",
      "Patients with PCP typically die due to refractory hypoxemia from severe respiratory failure , and corticosteroids have failed to demonstrate benefit outside of the HIV population [ 62 , 63 ] .\n",
      "['corticosteroids', '[c]Patients', 'HIV', 'PCP', 'benefit', 'refractory', '[', 'hypoxemia', 'refractory', 'die']\n",
      "===========================\n",
      "5 5\n",
      "Patients with PCP typically die due to refractory hypoxemia from severe respiratory failure , and corticosteroids have failed to demonstrate benefit outside of the HIV population [ 62 , 63 ] .\n",
      "['[p]Patients', 'HIV', '[c]PCP', 'population', 'with', 'refractory', 'refractory', 'severe', 'hypoxemia', 'corticosteroids']\n",
      "===========================\n",
      "5 6\n",
      "In addition , steroids are not effective for the treatment of lung injury or shock in adults ' SARS-CoV-2 infection [ 11 ] .\n",
      "['steroids', 'are', 'effective', 'lung', 'not', '[', 'shock', 'for', 'treatment', 'or']\n",
      "===========================\n",
      "5 6\n",
      "In addition , steroids are not effective for the treatment of lung injury or shock in adults ' SARS-CoV-2 infection [ 11 ] .\n",
      "['[c]infection', 'lung', 'shock', 'in', \"'\", '[p]steroids', '[p]or', 'injury', '[p][', 'adults']\n",
      "===========================\n",
      "5 7\n",
      "Corticosteroids in the treatment of SARS-CoV-2 pneumonia are not usually recommended ; they may delay virus clearance from the body [ 1 , 3 ] .\n",
      "['[c]Corticosteroids', 'they', 'are', 'virus', 'pneumonia', 'in', 'clearance', '[', 'body', 'treatment']\n",
      "===========================\n",
      "5 7\n",
      "Corticosteroids in the treatment of SARS-CoV-2 pneumonia are not usually recommended ; they may delay virus clearance from the body [ 1 , 3 ] .\n",
      "['virus', 'pneumonia', 'of', 'clearance', 'body', 'Corticosteroids', 'of', 'they', 'are', 'of']\n",
      "===========================\n",
      "5 8\n",
      "At present , there is no effective therapeutic agent against CVB3 , and only ribavirin is available for CVB3 infection despite its weak antiviral activity [ 93 ] .\n",
      "['ribavirin', 'only', 'antiviral', 'agent', 'therapeutic', 'is', 'infection', 'its', 'only', '[']\n",
      "===========================\n",
      "5 8\n",
      "At present , there is no effective therapeutic agent against CVB3 , and only ribavirin is available for CVB3 infection despite its weak antiviral activity [ 93 ] .\n",
      "['infection', 'CVB3', 'antiviral', 'CVB3', 'therapeutic', 'against', 'is', '[', 'against', 'for']\n",
      "===========================\n",
      "5 9\n",
      "Drugs currently licensed for the treatment of systemic CMV infections have limited therapeutic effectiveness due to dose-limiting toxicities , and prolonged therapy often results in resistance ( Biron , 2006 ) .\n",
      "['[c]Drugs', 'therapy', 'therapeutic', 'prolonged', 'resistance', '(', 'infections', 'CMV', 'licensed', 'systemic']\n",
      "===========================\n",
      "5 9\n",
      "Drugs currently licensed for the treatment of systemic CMV infections have limited therapeutic effectiveness due to dose-limiting toxicities , and prolonged therapy often results in resistance ( Biron , 2006 ) .\n",
      "['CMV', 'infections', 'systemic', '[c]Drugs', 'of', '(', 'resistance', 'therapy', 'therapeutic', 'have']\n",
      "===========================\n",
      "5 10\n",
      "Most of the TCM agents are mildly effective and slow-acting , and therefore , should not be used as the only treatment modality due to the rapid progression of disease .\n",
      "['agents', 'treatment', 'disease', '[c]effective', 'the', 'are', '[c]Most', 'TCM', 'modality', 'of']\n",
      "===========================\n",
      "5 10\n",
      "Most of the TCM agents are mildly effective and slow-acting , and therefore , should not be used as the only treatment modality due to the rapid progression of disease .\n",
      "['disease', 'agents', 'progression', 'treatment', 'of', 'are', 'effective', 'rapid', 'the', '[c]Most']\n",
      "===========================\n",
      "5 11\n",
      "In addition , antivirals such as NA inhibitors and M2 blockers have limited efficacy in severe cases of influenza infection if not administered within 48 hours from symptoms onset and may select for resistance .\n",
      "['antivirals', '[c],', 'blockers', 'efficacy', '[p]influenza', 'resistance', 'have', 'NA', '[c]inhibitors', '[c]and']\n",
      "===========================\n",
      "5 11\n",
      "In addition , antivirals such as NA inhibitors and M2 blockers have limited efficacy in severe cases of influenza infection if not administered within 48 hours from symptoms onset and may select for resistance .\n",
      "['influenza', 'infection', '[c]antivirals', 'severe', 'of', 'NA', 'symptoms', '[c]addition', ',', 'cases']\n",
      "===========================\n",
      "5 12\n",
      "The efficacy rate is also low in children , and the treatment is normally ineffective in secondary ITP with underlying diseases , such as systemic lupus erythematosus [ 25 ] .\n",
      "['treatment', 'efficacy', 'children', 'is', '[', 'is', '[c]The', 'the', 'rate', 'ineffective']\n",
      "===========================\n",
      "5 12\n",
      "The efficacy rate is also low in children , and the treatment is normally ineffective in secondary ITP with underlying diseases , such as systemic lupus erythematosus [ 25 ] .\n",
      "['[p]treatment', 'children', 'efficacy', '[c]underlying', '[p][', '[p]is', 'secondary', 'The', 'is', 'rate']\n",
      "===========================\n",
      "5 13\n",
      "However , the use of corticosteroids in the treatment of COVID-19 can cause host immune suppression and delay viral clearance .\n",
      "['[p]corticosteroids', 'use', 'immune', 'host', 'viral', 'of', 'clearance', '[c]However', 'can', 'treatment']\n",
      "===========================\n",
      "5 13\n",
      "However , the use of corticosteroids in the treatment of COVID-19 can cause host immune suppression and delay viral clearance .\n",
      "['host', 'viral', 'immune', 'However', 'can', 'clearance', 'corticosteroids', 'of', 'of', 'cause']\n",
      "===========================\n",
      "5 14\n",
      "However , the clinical use of interferon to treat dengue is not common , possibly due to IFN- side effects associated with its systemic activity .\n",
      "['[p]interferon', '[p]of', 'dengue', 'its', 'systemic', 'use', 'clinical', '[c]However', 'is', 'to']\n",
      "===========================\n",
      "5 14\n",
      "However , the clinical use of interferon to treat dengue is not common , possibly due to IFN- side effects associated with its systemic activity .\n",
      "['dengue', '[c]However', 'interferon', 'treat', 'is', 'systemic', 'its', 'of', 'activity', 'to']\n",
      "===========================\n",
      "5 15\n",
      "Unfortunately , a consistent benefit has not been observed in all clinical trials and ribavirin is currently not considered to be a drug of choice for influenza .\n",
      "['ribavirin', 'and', 'drug', 'clinical', 'influenza', 'trials', 'benefit', 'and', 'is', 'a']\n",
      "===========================\n",
      "5 15\n",
      "Unfortunately , a consistent benefit has not been observed in all clinical trials and ribavirin is currently not considered to be a drug of choice for influenza .\n",
      "['influenza', 'and', 'clinical', 'trials', 'all', 'for', 'benefit', 'is', 'in', 'has']\n",
      "===========================\n",
      "5 16\n",
      "For HSV encephalitis , the efficacy of aciclovir monotherapy may be hampered by limited penetration of the drug in the central nervous system .\n",
      "['aciclovir', 'drug', 'monotherapy', '[c]encephalitis', 'efficacy', 'of', 'central', 'may', 'the', 'penetration']\n",
      "===========================\n",
      "5 16\n",
      "For HSV encephalitis , the efficacy of aciclovir monotherapy may be hampered by limited penetration of the drug in the central nervous system .\n",
      "['encephalitis', '[c]HSV', '[c]For', 'penetration', 'drug', 'may', 'central', 'limited', 'of', 'in']\n",
      "===========================\n",
      "5 17\n",
      "Although , in a substantial cooperative study , high-dose acyclovir has had certain efficacy for preventing CMV disease ( 101 ) , its utility is limited in a setting where more potent anti-CMV agents ( e.g. , ganciclovir ) are used ( 102 ) .\n",
      "['acyclovir', 'agents', 'ganciclovir', 'its', 'high-dose', 'efficacy', 'CMV', 'disease', ',', ')']\n",
      "===========================\n",
      "5 17\n",
      "Although , in a substantial cooperative study , high-dose acyclovir has had certain efficacy for preventing CMV disease ( 101 ) , its utility is limited in a setting where more potent anti-CMV agents ( e.g. , ganciclovir ) are used ( 102 ) .\n",
      "['disease', 'CMV', 'setting', 'agents', 'preventing', 'is', 'anti-CMV', 'its', 'study', 'efficacy']\n",
      "===========================\n",
      "5 18\n",
      "While FAM is standard therapy for established BOS , recent data argue strongly against using azithromycin as prophylaxis against BOS due to decreased survival due to a higher rate of hematologic relapse [ 83 ] .\n",
      "['[c]FAM', 'azithromycin', 'is', 'therapy', 'survival', 'prophylaxis', 'hematologic', '[', 'BOS', 'BOS']\n",
      "===========================\n",
      "5 18\n",
      "While FAM is standard therapy for established BOS , recent data argue strongly against using azithromycin as prophylaxis against BOS due to decreased survival due to a higher rate of hematologic relapse [ 83 ] .\n",
      "['survival', 'BOS', 'BOS', 'established', 'hematologic', '[c]is', 'for', 'data', 'prophylaxis', 'relapse']\n",
      "===========================\n",
      "5 19\n",
      "Although a number of antivirals are available for influenza infections ( e.g. , M2 and neuraminidase inhibitors ) , these drugs have only modest efficacy and their use is further limited by resistance that is either preexisting or is rapidly induced during treatment ( 192 ) .\n",
      "['drugs', 'of', 'inhibitors', 'treatment', '[c]antivirals', 'influenza', 'these', 'efficacy', 'infections', 'use']\n",
      "===========================\n",
      "5 19\n",
      "Although a number of antivirals are available for influenza infections ( e.g. , M2 and neuraminidase inhibitors ) , these drugs have only modest efficacy and their use is further limited by resistance that is either preexisting or is rapidly induced during treatment ( 192 ) .\n",
      "['influenza', 'infections', 'treatment', 'drugs', 'resistance', 'of', 'antivirals', 'these', 'efficacy', 'and']\n",
      "===========================\n",
      "5 20\n",
      "Although immunosuppression is a mainstay of treatment for autoimmunity , IPEX treatment is frequently limited by insufficient response to therapy or side effects of immune suppression .\n",
      "['treatment', 'therapy', '[c]Although', 'is', 'immune', 'IPEX', 'autoimmunity', 'suppression', 'treatment', 'immunosuppression']\n",
      "===========================\n",
      "5 20\n",
      "Although immunosuppression is a mainstay of treatment for autoimmunity , IPEX treatment is frequently limited by insufficient response to therapy or side effects of immune suppression .\n",
      "['immune', 'autoimmunity', 'treatment', 'therapy', 'for', 'is', 'IPEX', 'treatment', 'suppression', 'or']\n",
      "===========================\n",
      "5 21\n",
      "There has traditionally been no specific treatment for CCHF , though ribavirin has demonstrated both in vitro and in vivo activity [ 40 ] .\n",
      "['ribavirin', 'though', 'treatment', 'activity', 'though', '[', '[c]There', 'has', 'specific', 'for']\n",
      "===========================\n",
      "5 21\n",
      "There has traditionally been no specific treatment for CCHF , though ribavirin has demonstrated both in vitro and in vivo activity [ 40 ] .\n",
      "['CCHF', 'treatment', 'activity', 'for', '[', 'has', 'for', 'though', 'specific', 'and']\n",
      "===========================\n",
      "5 22\n",
      "Although biologic therapies provide a valuable treatment option in UC , they are not clinically effective in all patients and are also associated with secondary loss of response .\n",
      "['[c]biologic', 'therapies', 'they', 'response', 'treatment', 'patients', 'UC', 'effective', 'are', 'clinically']\n",
      "===========================\n",
      "5 22\n",
      "Although biologic therapies provide a valuable treatment option in UC , they are not clinically effective in all patients and are also associated with secondary loss of response .\n",
      "['UC', 'patients', 'response', 'biologic', 'treatment', 'therapies', 'in', 'they', 'are', 'are']\n",
      "===========================\n",
      "5 23\n",
      "Currently , there is no vaccine to prevent RSV , and the only accepted therapy ( ribavirin ) is seldom used due to its teratogenicity , its limited antiviral effect , and its controversial clinical effectiveness ( 41 , 76 , 85 ) .\n",
      "['ribavirin', 'therapy', '(', 'RSV', 'antiviral', 'clinical', '(', 'is', 'vaccine', 'used']\n",
      "===========================\n",
      "5 23\n",
      "Currently , there is no vaccine to prevent RSV , and the only accepted therapy ( ribavirin ) is seldom used due to its teratogenicity , its limited antiviral effect , and its controversial clinical effectiveness ( 41 , 76 , 85 ) .\n",
      "['RSV', 'prevent', 'therapy', 'antiviral', 'clinical', 'vaccine', '[c]Currently', 'is', 'used', '(']\n",
      "===========================\n",
      "5 24\n",
      "Treatment with M2 inhibitors , such as amantadine , is generally not used in transplant recipients because of widespread resistance , the association with prolonged shedding of virus and increased adverse effects [ 6 , 30 ] .\n",
      "['Treatment', 'inhibitors', 'amantadine', 'is', 'transplant', 'recipients', 'virus', '[c]with', 'used', 'shedding']\n",
      "===========================\n",
      "5 24\n",
      "Treatment with M2 inhibitors , such as amantadine , is generally not used in transplant recipients because of widespread resistance , the association with prolonged shedding of virus and increased adverse effects [ 6 , 30 ] .\n",
      "['virus', 'transplant', 'Treatment', 'recipients', 'prolonged', 'shedding', 'is', 'resistance', 'of', 'in']\n",
      "===========================\n",
      "5 25\n",
      "Nevertheless , there is currently no definitive benefit proven for antiviral treatment outside of these specific circumstances , as it comes at a cost and may be associated with side effects ; for example , zanamivir can induce bronchospasms in patients with chronic respiratory disease and asthma .\n",
      "['zanamivir', 'antiviral', 'treatment', 'it', 'patients', '[c]there', 'induce', 'can', 'in', 'asthma']\n",
      "===========================\n",
      "5 25\n",
      "Nevertheless , there is currently no definitive benefit proven for antiviral treatment outside of these specific circumstances , as it comes at a cost and may be associated with side effects ; for example , zanamivir can induce bronchospasms in patients with chronic respiratory disease and asthma .\n",
      "['treatment', 'bronchospasms', 'antiviral', 'patients', 'in', 'asthma', 'induce', 'can', 'disease', 'with']\n",
      "===========================\n",
      "6 0\n",
      "Acute kidney injury is a possible manifestation in severe forms of COVID-19 , conferring a high mortality 7 .\n",
      "['[c]injury', '[c]kidney', '[c]Acute', 'is', 'severe', 'mortality', 'manifestation', 'a', 'of', 'of']\n",
      "===========================\n",
      "6 0\n",
      "Acute kidney injury is a possible manifestation in severe forms of COVID-19 , conferring a high mortality 7 .\n",
      "['severe', 'of', 'of', 'of', 'forms', 'is', '[c]in', 'COVID-19', 'mortality', 'injury']\n",
      "===========================\n",
      "6 1\n",
      "Coagulation dysfunction is one of the major causes for death in patients with severe COVID-19 [ 4 ] .\n",
      "['death', 'Coagulation', '[c]dysfunction', 'severe', '[c]is', 'patients', 'in', '[', 'severe', 'severe']\n",
      "===========================\n",
      "6 1\n",
      "Coagulation dysfunction is one of the major causes for death in patients with severe COVID-19 [ 4 ] .\n",
      "['patients', 'severe', '[', '[c]in', 'severe', 'with', 'is', 'death', 'severe', ']']\n",
      "===========================\n",
      "6 2\n",
      "Coagulopathy is one of the main complications occurring in hospitalized patients with severe COVID-19 .\n",
      "['is', 'complications', 'severe', 'Coagulopathy', 'hospitalized', 'in', 'patients', 'severe', 'severe', 'occurring']\n",
      "===========================\n",
      "6 2\n",
      "Coagulopathy is one of the main complications occurring in hospitalized patients with severe COVID-19 .\n",
      "['patients', 'severe', '[c]hospitalized', 'in', 'is', 'complications', 'severe', 'with', 'severe', 'COVID-19']\n",
      "===========================\n",
      "6 3\n",
      "Hypoxia is the most common manifestation of patients with COVID-19 , especially in severely or critically ill patients .\n",
      "['[c]Hypoxia', 'is', 'manifestation', 'patients', 'patients', 'common', 'of', 'with', 'with', 'severely']\n",
      "===========================\n",
      "6 3\n",
      "Hypoxia is the most common manifestation of patients with COVID-19 , especially in severely or critically ill patients .\n",
      "['patients', 'patients', 'with', 'is', 'with', 'with', 'Hypoxia', 'manifestation', 'common', 'of']\n",
      "===========================\n",
      "6 4\n",
      "Early-onset pneumonia is a common and severe complication that is related to aspiration in patients with GBS .\n",
      "['pneumonia', 'aspiration', 'complication', 'is', 'in', 'that', '[c]Early-onset', 'GBS', 'patients', '[c]severe']\n",
      "===========================\n",
      "6 4\n",
      "Early-onset pneumonia is a common and severe complication that is related to aspiration in patients with GBS .\n",
      "['patients', 'pneumonia', 'in', 'aspiration', 'complication', 'is', 'GBS', 'with', 'that', 'is']\n",
      "===========================\n",
      "6 5\n",
      "Barotrauma is a common complication in patients with SARS .\n",
      "['[c]Barotrauma', 'is', 'complication', 'SARS', 'with', 'in', 'patients', 'common', 'a', 'with']\n",
      "===========================\n",
      "6 5\n",
      "Barotrauma is a common complication in patients with SARS .\n",
      "['patients', 'SARS', '[c]is', 'in', 'with', 'complication', 'Barotrauma', 'common', 'with', 'a']\n",
      "===========================\n",
      "6 6\n",
      "COVID-19 infection is associated with several cardiac complications with high rates of adverse outcomes .\n",
      "['infection', 'cardiac', 'is', '[c]complications', 'adverse', 'associated', 'outcomes', '[c]COVID-19', 'with', 'with']\n",
      "===========================\n",
      "6 6\n",
      "COVID-19 infection is associated with several cardiac complications with high rates of adverse outcomes .\n",
      "['infection', '[c]is', 'cardiac', 'complications', '[c]associated', 'COVID-19', 'with', 'high', 'outcomes', 'with']\n",
      "===========================\n",
      "6 7\n",
      "AKI is one of the common complications with COVID-19 , and is associated with increased morbidity and mortality .\n",
      "['[c]AKI', 'is', 'is', 'complications', 'common', 'increased', 'associated', 'mortality', 'morbidity', 'with']\n",
      "===========================\n",
      "6 7\n",
      "AKI is one of the common complications with COVID-19 , and is associated with increased morbidity and mortality .\n",
      "['is', 'AKI', 'with', 'with', 'with', 'complications', 'is', ',', '[c]COVID-19', 'increased']\n",
      "===========================\n",
      "6 8\n",
      "Spontaneous pneumothorax is a specific and potentially life-threatening complication in SARS patients .\n",
      "['pneumothorax', '[c]complication', 'is', '[c]Spontaneous', 'SARS', 'patients', 'in', 'in', '[c]Spontaneous', '[c]a']\n",
      "===========================\n",
      "6 8\n",
      "Spontaneous pneumothorax is a specific and potentially life-threatening complication in SARS patients .\n",
      "['patients', 'SARS', 'in', 'is', 'complication', 'in', 'a', 'Spontaneous', '[c]pneumothorax', 'Spontaneous']\n",
      "===========================\n",
      "6 9\n",
      "COVID-19 pneumonia may lead to acute respiratory distress syndrome and severe respiratory failure ( 1 ) .\n",
      "['pneumonia', '[c]may', 'failure', 'and', 'severe', 'respiratory', '[p]to', 'syndrome', '[c](', '[c])']\n",
      "===========================\n",
      "6 9\n",
      "COVID-19 pneumonia may lead to acute respiratory distress syndrome and severe respiratory failure ( 1 ) .\n",
      "['pneumonia', 'may', '(', 'and', '[c]COVID-19', ')', '1', '[c]to', 'severe', 'lead']\n",
      "===========================\n",
      "6 10\n",
      "Pneumonia is the most frequent and serious complication of COVID-19 , due to excessive host immune response causing an acute respiratory distress syndrome .\n",
      "['[c]Pneumonia', 'is', 'complication', 'an', 'immune', 'host', 'syndrome', 'response', 'excessive', 'of']\n",
      "===========================\n",
      "6 10\n",
      "Pneumonia is the most frequent and serious complication of COVID-19 , due to excessive host immune response causing an acute respiratory distress syndrome .\n",
      "['Pneumonia', '[c]of', 'is', '[c]of', '[c]of', 'complication', 'host', 'immune', 'COVID-19', 'an']\n",
      "===========================\n",
      "6 11\n",
      "Acute respiratory distress syndrome developing in patients with COVID-19 pneumonia is associated with a high mortality rate and is the main cause of death in patients with SRAS-Cov-2 infection [ 1 ] .\n",
      "['pneumonia', 'syndrome', 'is', 'developing', 'in', 'mortality', 'infection', 'is', 'death', 'patients']\n",
      "===========================\n",
      "6 11\n",
      "Acute respiratory distress syndrome developing in patients with COVID-19 pneumonia is associated with a high mortality rate and is the main cause of death in patients with SRAS-Cov-2 infection [ 1 ] .\n",
      "['infection', 'pneumonia', 'patients', 'patients', 'is', 'in', '[c]in', '[', 'with', 'with']\n",
      "===========================\n",
      "6 12\n",
      "Pneumonia is a life-threatening complication of COVID-19 infection 10 .\n",
      "['[c]Pneumonia', 'is', 'infection', 'complication', 'of', 'a', '10', 'a', 'life-threatening', 'of']\n",
      "===========================\n",
      "6 12\n",
      "Pneumonia is a life-threatening complication of COVID-19 infection 10 .\n",
      "['infection', '[p]Pneumonia', 'is', '[p]of', '[p]of', '[c]10', '[p]of', 'complication', 'COVID-19', 'a']\n",
      "===========================\n",
      "6 13\n",
      "ARDS and shock are common complications that can lead to death in COVID-19 patients .\n",
      "['shock', '[c]ARDS', 'death', 'common', 'complications', 'are', 'patients', 'in', '[c]and', 'that']\n",
      "===========================\n",
      "6 13\n",
      "ARDS and shock are common complications that can lead to death in COVID-19 patients .\n",
      "['patients', 'in', 'in', 'in', 'are', 'shock', 'common', 'complications', 'death', 'COVID-19']\n",
      "===========================\n",
      "6 14\n",
      "Multiorgan injury , which significantly increases mortality , is often evident in patients with COVID-19 .\n",
      "['injury', '[c]mortality', 'is', 'patients', 'evident', 'in', '[c]Multiorgan', 'which', 'with', 'with']\n",
      "===========================\n",
      "6 14\n",
      "Multiorgan injury , which significantly increases mortality , is often evident in patients with COVID-19 .\n",
      "['patients', 'with', 'with', 'in', 'with', 'mortality', '[c]is', 'injury', 'COVID-19', 'evident']\n",
      "===========================\n",
      "6 15\n",
      "Acute IH is a significant complication of high-dose IVIg infusion .\n",
      "['[c]IH', '[c]Acute', 'is', 'infusion', 'complication', 'IVIg', 'of', 'a', 'significant', 'high-dose']\n",
      "===========================\n",
      "6 15\n",
      "Acute IH is a significant complication of high-dose IVIg infusion .\n",
      "['infusion', 'is', '[c]Acute', '[p]of', '[c]complication', 'IVIg', 'high-dose', 'IH', '[p]of', 'a']\n",
      "===========================\n",
      "6 16\n",
      "Multiorgan failure and disseminated intravascular coagulation ( DIC ) are also frequently observed during COVID-19 infection .\n",
      "['DIC', '[c]failure', 'infection', 'are', 'and', '[p]during', 'observed', '[c]also', 'coagulation', 'frequently']\n",
      "===========================\n",
      "6 16\n",
      "Multiorgan failure and disseminated intravascular coagulation ( DIC ) are also frequently observed during COVID-19 infection .\n",
      "['infection', 'during', 'are', 'during', 'observed', 'during', 'and', 'COVID-19', 'also', 'frequently']\n",
      "===========================\n",
      "6 17\n",
      "Acute Respiratory Distress Syndrome ( ARDS ) is one of the commonest complications developing in patients with COVID-19 [ 6 ] .\n",
      "['ARDS', 'is', 'complications', '[c]Syndrome', '[p]in', 'patients', '[c]developing', '[', 'with', 'with']\n",
      "===========================\n",
      "6 17\n",
      "Acute Respiratory Distress Syndrome ( ARDS ) is one of the commonest complications developing in patients with COVID-19 [ 6 ] .\n",
      "['patients', 'with', 'in', '[', 'with', 'with', 'is', 'complications', 'COVID-19', 'developing']\n",
      "===========================\n",
      "6 18\n",
      "Cardiac injury is a common condition among the hospitalized patients with COVID-19 .\n",
      "['[c]injury', '[c]Cardiac', 'is', 'hospitalized', 'condition', 'common', 'patients', 'a', 'with', 'with']\n",
      "===========================\n",
      "6 18\n",
      "Cardiac injury is a common condition among the hospitalized patients with COVID-19 .\n",
      "['patients', 'hospitalized', 'with', 'with', 'is', 'with', 'injury', 'COVID-19', 'Cardiac', 'condition']\n",
      "===========================\n",
      "6 19\n",
      "DIC is a severe complication in COVID-19 patients and it has been related to poor prognosis and increased mortality ( 71.4 % of patient who die of COVID-19 ) ( 2 ) .\n",
      "['[c]DIC', 'complication', 'is', 'patients', 'it', 'severe', 'mortality', ')', 'in', 'prognosis']\n",
      "===========================\n",
      "6 19\n",
      "DIC is a severe complication in COVID-19 patients and it has been related to poor prognosis and increased mortality ( 71.4 % of patient who die of COVID-19 ) ( 2 ) .\n",
      "['patients', 'in', 'and', ')', 'complication', 'is', 'patient', 'DIC', 'in', 'it']\n",
      "===========================\n",
      "6 20\n",
      "Thrombocytopenia is one of the most common symptoms in patients with COVID-19 .\n",
      "['[c]Thrombocytopenia', 'is', 'symptoms', 'in', 'with', 'patients', 'common', 'with', 'one', 'with']\n",
      "===========================\n",
      "6 20\n",
      "Thrombocytopenia is one of the most common symptoms in patients with COVID-19 .\n",
      "['patients', 'in', 'is', 'with', 'with', 'with', '[c]symptoms', 'COVID-19', 'common', 'one']\n",
      "===========================\n",
      "6 21\n",
      "AKI occurs frequently among patients with Covid-19 disease .\n",
      "['[p]AKI', 'disease', 'occurs', 'patients', 'with', 'frequently', 'among', 'with', 'Covid-19', 'with']\n",
      "===========================\n",
      "6 21\n",
      "AKI occurs frequently among patients with Covid-19 disease .\n",
      "['disease', 'patients', '[p]AKI', 'with', 'with', 'with', 'occurs', 'among', 'Covid-19', 'frequently']\n",
      "===========================\n",
      "6 22\n",
      "AKI occurs frequently among patients with Covid-19 disease .\n",
      "['[p]AKI', 'disease', 'occurs', 'patients', 'with', 'frequently', 'among', 'with', 'Covid-19', 'with']\n",
      "===========================\n",
      "6 22\n",
      "AKI occurs frequently among patients with Covid-19 disease .\n",
      "['disease', 'patients', '[p]AKI', 'with', 'with', 'with', 'occurs', 'among', 'Covid-19', 'frequently']\n",
      "===========================\n",
      "6 23\n",
      "HTN is a comorbid condition which has been reported to be associated with increased mortality in patients with COVID-19 infection .\n",
      "['mortality', 'is', 'infection', 'HTN', 'condition', 'patients', '[c]comorbid', 'a', 'in', 'with']\n",
      "===========================\n",
      "6 23\n",
      "HTN is a comorbid condition which has been reported to be associated with increased mortality in patients with COVID-19 infection .\n",
      "['infection', 'patients', 'is', 'mortality', 'in', 'with', 'with', 'with', 'condition', 'a']\n",
      "===========================\n",
      "6 24\n",
      "AKI is a common consequence of COVID-19 , either due to ATN or hypotension .\n",
      "['[c]AKI', 'hypotension', 'is', 'common', 'ATN', 'consequence', 'of', 'a', 'or', 'to']\n",
      "===========================\n",
      "6 24\n",
      "AKI is a common consequence of COVID-19 , either due to ATN or hypotension .\n",
      "['is', 'of', 'AKI', 'of', 'hypotension', 'of', 'common', 'COVID-19', 'or', 'a']\n",
      "===========================\n",
      "6 25\n",
      "Acute respiratory distress is one of the major causes of mortality associated with COVID-19 disease .\n",
      "['disease', 'mortality', 'Acute', 'is', '[c]distress', 'respiratory', 'with', 'with', 'with', '[c]one']\n",
      "===========================\n",
      "6 25\n",
      "Acute respiratory distress is one of the major causes of mortality associated with COVID-19 disease .\n",
      "['disease', 'is', 'with', 'with', 'mortality', 'with', '[p]Acute', 'associated', 'COVID-19', 'respiratory']\n",
      "===========================\n",
      "6 26\n",
      "RSV-induced ARDS is very uncommon but can be lethal in immunocompetent patients .\n",
      "['ARDS', '[c]RSV-induced', 'is', '[c]RSV-induced', 'lethal', 'patients', 'in', 'in', 'be', 'can']\n",
      "===========================\n",
      "6 26\n",
      "RSV-induced ARDS is very uncommon but can be lethal in immunocompetent patients .\n",
      "['patients', '[c]is', 'RSV-induced', 'in', 'ARDS', 'in', 'but', '[c]lethal', 'RSV-induced', 'immunocompetent']\n",
      "===========================\n",
      "7 0\n",
      "If we aim to control the failure rate of quarantine to be below 1 % with 95 % confidence , then the quarantine period must be at least 22 days .\n",
      "['quarantine', 'quarantine', 'the', 'of', 'period', 'the', 'of', 'of', 'failure', 'the']\n",
      "===========================\n",
      "7 0\n",
      "If we aim to control the failure rate of quarantine to be below 1 % with 95 % confidence , then the quarantine period must be at least 22 days .\n",
      "['22', 'days', 'period', 'the', 'failure', 'of', 'be', 'quarantine', '[p]must', 'of']\n",
      "===========================\n",
      "7 1\n",
      "In general , the duration of the quarantine period should be 21 to 30 days .\n",
      "['[p]quarantine', 'period', '[p]the', '[p]the', '[p]duration', 'be', 'of', '[p]the', '[c]general', 'days']\n",
      "===========================\n",
      "7 1\n",
      "In general , the duration of the quarantine period should be 21 to 30 days .\n",
      "['30', 'days', '[p]21', 'duration', 'period', 'be', 'of', 'should', '[c]general', 'the']\n",
      "===========================\n",
      "7 2\n",
      "Although for extreme cases , the quarantine period should be extended up to three weeks .\n",
      "['quarantine', 'the', 'period', 'the', 'the', 'be', 'cases', 'weeks', 'to', 'three']\n",
      "===========================\n",
      "7 2\n",
      "Although for extreme cases , the quarantine period should be extended up to three weeks .\n",
      "['three', 'the', 'weeks', 'period', 'to', '[c]extreme', 'up', '[c]Although', 'cases', 'be']\n",
      "===========================\n",
      "7 3\n",
      "At the beginning and the end of a SARS epidemic , to control the epidemic completely , we recommend a period of 22 days for quarantine , which would capture 99 percent of all probable SARS cases with a probability of 0.9 .\n",
      "['quarantine', 'for', 'epidemic', 'period', 'a', 'SARS', 'control', 'SARS', 'epidemic', 'for']\n",
      "===========================\n",
      "7 3\n",
      "At the beginning and the end of a SARS epidemic , to control the epidemic completely , we recommend a period of 22 days for quarantine , which would capture 99 percent of all probable SARS cases with a probability of 0.9 .\n",
      "['22', 'days', 'period', 'for', 'a', '[c]At', 'control', 'we', 'of', 'which']\n",
      "===========================\n",
      "7 4\n",
      "Based on the 95th percentile estimate of the incubation period , we recommend that the length of quarantine should be at least 14 days .\n",
      "['quarantine', 'of', 'of', 'incubation', 'period', 'of', 'be', '[p]estimate', 'of', '[p]we']\n",
      "===========================\n",
      "7 4\n",
      "Based on the 95th percentile estimate of the incubation period , we recommend that the length of quarantine should be at least 14 days .\n",
      "['14', '[p]days', 'incubation', 'period', 'we', 'of', 'of', 'length', '[c]on', 'be']\n",
      "===========================\n",
      "7 5\n",
      "As such , the quarantine period should be extended up to three weeks .\n",
      "['quarantine', 'the', 'period', 'the', 'the', 'be', 'weeks', 'to', 'extended', 'three']\n",
      "===========================\n",
      "7 5\n",
      "As such , the quarantine period should be extended up to three weeks .\n",
      "['three', 'weeks', '[p]period', 'the', 'to', 'up', 'extended', 'be', 'should', 'the']\n",
      "===========================\n",
      "7 6\n",
      "For example , if the rate of transmission is reduced by 10 % , the quarantine from symptom onset needs to be implemented within 32.37 h+.\n",
      "['quarantine', 'the', 'the', 'be', 'symptom', '[p]transmission', 'onset', 'the', 'of', 'rate']\n",
      "===========================\n",
      "7 6\n",
      "For example , if the rate of transmission is reduced by 10 % , the quarantine from symptom onset needs to be implemented within 32.37 h+.\n",
      "['within', 'the', 'symptom', '[c]10', 'within', 'implemented', 'be', 'example', 'transmission', 'reduced']\n",
      "===========================\n",
      "7 7\n",
      "If testing is not done , the quarantine period should at least exceed the incubation and shedding period of the diseases of concern .\n",
      "['quarantine', 'the', 'period', 'the', 'testing', 'the', 'shedding', 'period', 'of', 'the']\n",
      "===========================\n",
      "7 7\n",
      "If testing is not done , the quarantine period should at least exceed the incubation and shedding period of the diseases of concern .\n",
      "['[p]period', '[c]the', 'testing', 'should', 'of', 'exceed', '[c]period', '[p]the', 'and', 'is']\n",
      "===========================\n",
      "7 8\n",
      "Therefore , the quarantine period should be around 2 weeks after a close contact with a person with symptoms .\n",
      "['quarantine', 'period', 'the', 'contact', 'the', 'person', 'be', 'close', 'the', 'with']\n",
      "===========================\n",
      "7 8\n",
      "Therefore , the quarantine period should be around 2 weeks after a close contact with a person with symptoms .\n",
      "['2', 'after', 'weeks', '[p]period', 'around', 'be', 'a', '[c]Therefore', 'close', '[c]the']\n",
      "===========================\n",
      "7 9\n",
      "As per the CDC guidelines , 14 days should be the period of quarantine ( Science Daily website ) .\n",
      "['quarantine', 'of', 'of', 'period', 'be', '(', 'of', 'the', ')', '[c]As']\n",
      "===========================\n",
      "7 9\n",
      "As per the CDC guidelines , 14 days should be the period of quarantine ( Science Daily website ) .\n",
      "['14', 'days', 'period', '(', 'be', ')', 'of', 'the', 'should', 'of']\n",
      "===========================\n",
      "7 10\n",
      "The quarantine period is typically 30 days .\n",
      "['quarantine', '[c]The', '[c]period', '[c]The', '[c]The', 'is', 'days', '30', 'typically']\n",
      "===========================\n",
      "7 10\n",
      "The quarantine period is typically 30 days .\n",
      "['30', 'days', 'is', 'period', '[c]The', 'typically', '[c]The', '[c]quarantine', '[c]The']\n",
      "===========================\n",
      "7 11\n",
      "Because a longer and more volatile incubation period has been observed in travelers , the duration of quarantine should be extended to 3 weeks .\n",
      "['quarantine', 'of', 'of', 'incubation', 'period', 'travelers', 'in', 'in', 'be', 'of']\n",
      "===========================\n",
      "7 11\n",
      "Because a longer and more volatile incubation period has been observed in travelers , the duration of quarantine should be extended to 3 weeks .\n",
      "['3', 'of', 'weeks', 'to', 'duration', 'in', 'incubation', 'period', 'travelers', 'extended']\n",
      "===========================\n",
      "7 12\n",
      "The time for which a patient can infect others varies between 7 and 14 days for moderate cases according to [ 3 ] , and this is why quarantine should last at least two weeks .\n",
      "['quarantine', 'why', 'why', 'time', 'patient', 'cases', '[c]The', 'infect', 'last', 'can']\n",
      "===========================\n",
      "7 12\n",
      "The time for which a patient can infect others varies between 7 and 14 days for moderate cases according to [ 3 ] , and this is why quarantine should last at least two weeks .\n",
      "['14', 'days', 'time', '7', 'two', 'The', '[', 'moderate', 'weeks', 'for']\n",
      "===========================\n",
      "7 13\n",
      "Therefore , we suggest that the appropriate duration of quarantine is 4 days .\n",
      "['quarantine', 'of', 'of', 'duration', 'is', 'of', 'that', 'appropriate', '[p]we', 'days']\n",
      "===========================\n",
      "7 13\n",
      "Therefore , we suggest that the appropriate duration of quarantine is 4 days .\n",
      "['4', 'days', 'is', 'duration', 'of', '[c]Therefore', 'we', 'of', 'that', 'appropriate']\n",
      "===========================\n",
      "7 14\n",
      "A quarantine period of at least 15 days should allow adequate time for the return and evaluation of test data .\n",
      "['quarantine', '[c]A', '[c]period', 'test', 'data', '[c]A', '[c]A', 'time', 'of', 'of']\n",
      "===========================\n",
      "7 14\n",
      "A quarantine period of at least 15 days should allow adequate time for the return and evaluation of test data .\n",
      "['15', 'days', '[c]A', 'adequate', 'should', 'period', 'test', 'data', 'for', 'time']\n",
      "===========================\n",
      "7 15\n",
      "At the moment , the WHO-established quarantine period is 14 days based on previous reports which had studied small sizes of hospitalized cases ( 10 and ~100 , respectively ) , however , over 80 % of adult- and 95 % of child-cases were not necessary to stay in hospitals , and therefore , had not been hospitalized .\n",
      "['quarantine', 'WHO-established', 'period', 'WHO-established', 'the', 'is', 'cases', 'of', 'in', 'hospitalized']\n",
      "===========================\n",
      "7 15\n",
      "At the moment , the WHO-established quarantine period is 14 days based on previous reports which had studied small sizes of hospitalized cases ( 10 and ~100 , respectively ) , however , over 80 % of adult- and 95 % of child-cases were not necessary to stay in hospitals , and therefore , had not been hospitalized .\n",
      "['14', 'days', 'is', '10', '~100', 'period', 'to', 'the', 'not', 'were']\n",
      "===========================\n",
      "7 16\n",
      "Quarantine duration depends on national regulations but should be a minimum of 30 days .\n",
      "['[c]Quarantine', '[p]duration', 'national', 'of', 'days', 'be', '30', 'but', 'on', 'minimum']\n",
      "===========================\n",
      "7 16\n",
      "Quarantine duration depends on national regulations but should be a minimum of 30 days .\n",
      "['30', 'days', '[c]duration', '[p]national', 'of', '[c]Quarantine', 'minimum', 'regulations', 'on', '[p]a']\n",
      "===========================\n",
      "7 17\n",
      "We recommend that the duration of quarantine should be at least 14 days on the basis of the 95th percentile estimate of the incubation period ( 10 ) .\n",
      "['[p]quarantine', 'of', 'of', 'incubation', 'of', 'period', '[p]duration', 'be', '[c]We', 'estimate']\n",
      "===========================\n",
      "7 17\n",
      "We recommend that the duration of quarantine should be at least 14 days on the basis of the 95th percentile estimate of the incubation period ( 10 ) .\n",
      "['14', 'days', 'duration', '10', 'incubation', 'of', 'period', '[c]We', 'the', 'be']\n",
      "===========================\n",
      "7 18\n",
      "A minimum quarantine period of 60 to 90 days is recommended in a building that is separate from the main facility .\n",
      "['quarantine', 'period', '[p]minimum', '[p]minimum', 'is', 'in', 'main', 'of', 'facility', 'building']\n",
      "===========================\n",
      "7 18\n",
      "A minimum quarantine period of 60 to 90 days is recommended in a building that is separate from the main facility .\n",
      "['90', '60', 'is', 'days', '[c]A', 'recommended', '[c]period', '[c]minimum', 'main', 'in']\n",
      "===========================\n",
      "7 19\n",
      "The quarantine period , which starts when the most recently received animals are placed into a quarantine , should not be less than several weeks , to allow time for seroconversion to infectious agents acquired in transit .\n",
      "['quarantine', 'quarantine', '[c]The', 'for', '[p]period', '[c]The', 'a', 'seroconversion', '[c]The', 'are']\n",
      "===========================\n",
      "7 19\n",
      "The quarantine period , which starts when the most recently received animals are placed into a quarantine , should not be less than several weeks , to allow time for seroconversion to infectious agents acquired in transit .\n",
      "['several', '[c]The', 'period', 'weeks', 'animals', 'the', 'for', '[p]infectious', 'for', '[p]a']\n",
      "===========================\n",
      "7 20\n",
      "The incubation period of SARS was described as 20 days , meaning a quarantine officer could detain a person suspected of having SARS up to that period of time .\n",
      "['quarantine', 'SARS', 'time', 'incubation', 'a', 'person', '[c]The', 'SARS', 'officer', 'of']\n",
      "===========================\n",
      "7 20\n",
      "The incubation period of SARS was described as 20 days , meaning a quarantine officer could detain a person suspected of having SARS up to that period of time .\n",
      "['20', 'days', 'was', '[c]The', '[c]incubation', 'as', 'of', 'time', 'period', 'of']\n",
      "===========================\n",
      "7 21\n",
      "Upon the finding of longer and more volatile incubation period in travelers , the duration of quarantine should be extended to three weeks .\n",
      "['quarantine', 'of', 'of', 'incubation', 'period', 'be', 'travelers', 'of', '[p]in', '[p]in']\n",
      "===========================\n",
      "7 21\n",
      "Upon the finding of longer and more volatile incubation period in travelers , the duration of quarantine should be extended to three weeks .\n",
      "['three', 'of', 'in', 'duration', 'to', 'weeks', 'incubation', 'period', 'travelers', 'be']\n",
      "===========================\n",
      "7 22\n",
      "If there is a potential exposure risk during the process , a 14-day quarantine is required .\n",
      "['quarantine', 'process', '14-day', 'is', '14-day', 'exposure', 'required', '14-day', 'risk', 'a']\n",
      "===========================\n",
      "7 22\n",
      "If there is a potential exposure risk during the process , a 14-day quarantine is required .\n",
      "['[c]a', '14-day', 'is', '[c]a', '[c]a', 'required', 'process', 'during', 'risk', '[c]there']\n",
      "===========================\n",
      "7 23\n",
      "We recommend a 22-day quarantine period .\n",
      "['quarantine', '22-day', 'period', '22-day', '22-day', '[p]a', '[p]a', '[c]We', 'recommend', '[p]a']\n",
      "===========================\n",
      "7 23\n",
      "We recommend a 22-day quarantine period .\n",
      "['a', '22-day', 'period', 'a', 'a', 'We', '22-day', '[c]recommend', 'quarantine', '22-day']\n",
      "===========================\n",
      "7 24\n",
      "From official reports , the quarantine buffer in January is around 15 d and around 6 d on February 8 .\n",
      "['quarantine', 'the', 'the', 'the', 'official', '[p]in', 'is', 'buffer', 'reports', 'd']\n",
      "===========================\n",
      "7 24\n",
      "From official reports , the quarantine buffer in January is around 15 d and around 6 d on February 8 .\n",
      "['15', '6', 'the', 'is', 'official', '8', 'd', '[c]From', 'in', 'reports']\n",
      "===========================\n",
      "7 25\n",
      "The incubation period alone suggests that 95 % effectiveness in preventing the release of symptomatic infected individuals is achieved by quarantine of 2.73 days .\n",
      "['quarantine', 'by', 'incubation', 'period', '[c]The', 'infected', 'of', 'of', 'is', 'symptomatic']\n",
      "===========================\n",
      "7 25\n",
      "The incubation period alone suggests that 95 % effectiveness in preventing the release of symptomatic infected individuals is achieved by quarantine of 2.73 days .\n",
      "['days', '2.73', '[c]The', 'period', 'of', 'is', 'of', '[c]incubation', 'symptomatic', 'suggests']\n",
      "===========================\n",
      "8 0\n",
      "SARS-CoV targets human angiotensin-converting enzyme 2 ( hACE2 ) and infects +intrapulmonary epithelial cells+ more than cells of the upper airways [ 13 , 14 ] .\n",
      "['2', 'hACE2', 'SARS-CoV', '[', '(', 'more', 'cells+', 'infects', 'and', '[c]human']\n",
      "===========================\n",
      "8 0\n",
      "SARS-CoV targets human angiotensin-converting enzyme 2 ( hACE2 ) and infects +intrapulmonary epithelial cells+ more than cells of the upper airways [ 13 , 14 ] .\n",
      "['epithelial', 'cells', 'epithelial', 'airways', 'the', '[', '+intrapulmonary', '[c]human', 'infects', 'cells+']\n",
      "===========================\n",
      "8 1\n",
      "SARS-CoV-2 infects ACE2 + cells in the oral mucosa and lungs , including ACE-2 cells in the alveoli [ 97 ] .\n",
      "['[c]SARS-CoV-2', 'ACE-2', 'ACE2', 'infects', '[', '[c]SARS-CoV-2', 'cells', 'cells', 'infects', 'oral']\n",
      "===========================\n",
      "8 1\n",
      "SARS-CoV-2 infects ACE2 + cells in the oral mucosa and lungs , including ACE-2 cells in the alveoli [ 97 ] .\n",
      "['cells', 'cells', 'oral', 'the', 'lungs', 'mucosa', 'in', '[c]infects', '[', 'the']\n",
      "===========================\n",
      "8 2\n",
      "Like other viruses , SARS-CoV-2 infects lung alveolar epithelial cells using receptor-mediated endocytosis via the angiotensin-converting enzyme II ( ACE2 ) as an entry receptor [ 4 ] .\n",
      "['SARS-CoV-2', 'ACE2', 'II', ',', ',', ',', 'lung', 'viruses', '[c]an', '[']\n",
      "===========================\n",
      "8 2\n",
      "Like other viruses , SARS-CoV-2 infects lung alveolar epithelial cells using receptor-mediated endocytosis via the angiotensin-converting enzyme II ( ACE2 ) as an entry receptor [ 4 ] .\n",
      "['cells', 'lung', 'epithelial', 'alveolar', 'receptor', '[c]viruses', 'endocytosis', 'infects', 'using', '[']\n",
      "===========================\n",
      "8 3\n",
      "Initially , SARS-CoV-2 infects cells in the respiratory system and causes inflammation and cell death .\n",
      "['SARS-CoV-2', ',', ',', ',', 'respiratory', '[c]causes', '[c]Initially', 'inflammation', 'infects', ',']\n",
      "===========================\n",
      "8 3\n",
      "Initially , SARS-CoV-2 infects cells in the respiratory system and causes inflammation and cell death .\n",
      "['[c]cells', 'respiratory', 'inflammation', 'cell', 'system', '[p]in', '[c]Initially', 'causes', '[p]and', 'the']\n",
      "===========================\n",
      "8 4\n",
      "The SARA-CoV-2 primarily invades alveolar epithelial cells and interacts with ACE2 , leading to respiratory symptoms in patients [ 33 ] .\n",
      "['SARA-CoV-2', 'ACE2', '[c]The', '[c]The', '[p]primarily', '[c]The', 'patients', '[c]The', 'respiratory', '[']\n",
      "===========================\n",
      "8 4\n",
      "The SARA-CoV-2 primarily invades alveolar epithelial cells and interacts with ACE2 , leading to respiratory symptoms in patients [ 33 ] .\n",
      "['cells', 'patients', 'alveolar', 'epithelial', 'respiratory', '[c]The', 'in', '[c]primarily', '[', 'to']\n",
      "===========================\n",
      "8 5\n",
      "In the lungs , SARS-CoV-2 infects type I and type II alveolar epithelial cells , as well as alveolar macrophages that are among the first producers of pro-inflammatory cytokines .\n",
      "['SARS-CoV-2', ',', ',', ',', '[c]In', 'infects', ',', '[c]alveolar', 'alveolar', 'the']\n",
      "===========================\n",
      "8 5\n",
      "In the lungs , SARS-CoV-2 infects type I and type II alveolar epithelial cells , as well as alveolar macrophages that are among the first producers of pro-inflammatory cytokines .\n",
      "['cells', '[c]alveolar', 'epithelial', 'alveolar', '[c]In', '[c]lungs', '[c]the', 'that', '[p]cytokines', 'are']\n",
      "===========================\n",
      "8 6\n",
      "SARS-CoV-2 binds to the ACE2 receptor on ciliated bronchial epithelial cells to gain entry into these cells for viral replication and dissemination in the airway [ 6 ] .\n",
      "['[c]SARS-CoV-2', 'ACE2', 'viral', '[', 'airway', '6', 'bronchial', 'binds', 'the', 'and']\n",
      "===========================\n",
      "8 6\n",
      "SARS-CoV-2 binds to the ACE2 receptor on ciliated bronchial epithelial cells to gain entry into these cells for viral replication and dissemination in the airway [ 6 ] .\n",
      "['cells', 'airway', 'cells', 'bronchial', 'epithelial', 'these', '[c]viral', '[', 'receptor', '[c]the']\n",
      "===========================\n",
      "8 7\n",
      "SARS-CoV-2 infects ACE2positive cells in the oral mucosa and lungs , including ACE2 + AT2 cells in the alveoli .\n",
      "['[c]SARS-CoV-2', 'infects', 'ACE2', 'AT2', 'infects', '[c]SARS-CoV-2', 'including', 'infects', 'cells', 'cells']\n",
      "===========================\n",
      "8 7\n",
      "SARS-CoV-2 infects ACE2positive cells in the oral mucosa and lungs , including ACE2 + AT2 cells in the alveoli .\n",
      "['cells', 'cells', 'oral', 'the', 'lungs', '[c]infects', 'mucosa', 'in', '[c]the', 'including']\n",
      "===========================\n",
      "8 8\n",
      "SARS-CoV enters host cells by a mechanism involving the interaction between its spike ( S ) protein and human angiotensin-converting enzyme 2 ( ACE2 ) expressed on host cells in the lung [ 5 ] .\n",
      "['2', 'SARS-CoV', 'ACE2', 'its', 'lung', 'protein', '[', 'host', 'human', 'in']\n",
      "===========================\n",
      "8 8\n",
      "SARS-CoV enters host cells by a mechanism involving the interaction between its spike ( S ) protein and human angiotensin-converting enzyme 2 ( ACE2 ) expressed on host cells in the lung [ 5 ] .\n",
      "['cells', 'host', 'cells', 'lung', 'host', '[', 'human', 'its', 'mechanism', 'in']\n",
      "===========================\n",
      "8 9\n",
      "Research has demonstrated that COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , which enters the cells by binding to the angiotensin-converting enzyme 2 ( ACE2 ) receptor .\n",
      "['SARS-CoV-2', '2', '2', 'COVID-19', 'ACE2', 'is', '[c]that', 'which', '[c]that', '[c]that']\n",
      "===========================\n",
      "8 9\n",
      "Research has demonstrated that COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , which enters the cells by binding to the angiotensin-converting enzyme 2 ( ACE2 ) receptor .\n",
      "['cells', 'the', 'is', '[c]Research', 'that', '[c]has', 'which', 'receptor', 'by', 'that']\n",
      "===========================\n",
      "8 10\n",
      "SARS-CoV-2 invades target cells via its spike proteins , which bind to angiotensin-converting enzyme (ACE)-2 receptors that are widely distributed in many types of human cells , including the alveolar type II cells in the lungs [ 71 , 72 ] .\n",
      "['[c]SARS-CoV-2', '(ACE)-2', 'proteins', 'its', '[c]SARS-CoV-2', 'which', 'are', 'II', '[', 'spike']\n",
      "===========================\n",
      "8 10\n",
      "SARS-CoV-2 invades target cells via its spike proteins , which bind to angiotensin-converting enzyme (ACE)-2 receptors that are widely distributed in many types of human cells , including the alveolar type II cells in the lungs [ 71 , 72 ] .\n",
      "['[c]cells', 'cells', 'target', '[p]human', 'cells', 'lungs', 'proteins', '[p]its', 'of', 'the']\n",
      "===========================\n",
      "8 11\n",
      "SARS-CoV-2 infects human epithelial cells through the host cell receptor angiotensin-converting enzyme II ( ACE2 ) , which is expressed on cells lining the lungs , oral buccal and gingiva ( 19 ) .\n",
      "['[c]SARS-CoV-2', 'ACE2', 'II', 'is', 'human', '19', '[c]SARS-CoV-2', 'epithelial', 'host', 'infects']\n",
      "===========================\n",
      "8 11\n",
      "SARS-CoV-2 infects human epithelial cells through the host cell receptor angiotensin-converting enzyme II ( ACE2 ) , which is expressed on cells lining the lungs , oral buccal and gingiva ( 19 ) .\n",
      "['cells', 'epithelial', '[c]human', 'cells', 'lungs', 'host', 'the', 'oral', 'cell', 'is']\n",
      "===========================\n",
      "8 12\n",
      "SARS-CoV-2 can infect cells via the angiotensin-converting enzyme 2 ( ACE2 ) receptor which is ubiquitous but largely expressed in endothelial cells [ 10 ] .\n",
      "['[c]SARS-CoV-2', '2', 'ACE2', 'can', 'infect', 'endothelial', 'cells', 'receptor', '[', 'is']\n",
      "===========================\n",
      "8 12\n",
      "SARS-CoV-2 can infect cells via the angiotensin-converting enzyme 2 ( ACE2 ) receptor which is ubiquitous but largely expressed in endothelial cells [ 10 ] .\n",
      "['cells', 'cells', 'endothelial', '[c]can', '[c]infect', '[', 'receptor', 'in', 'which', 'is']\n",
      "===========================\n",
      "8 13\n",
      "Similar to SARS-CoV , SARS-CoV-2 exploits angiotensin-converting enzyme 2 ( ACE2 ) as a receptor to invade cells , notably type II alveolar epithelial cells .\n",
      "['SARS-CoV-2', '2', 'ACE2', 'SARS-CoV', ',', ',', 'a', 'alveolar', 'receptor', 'exploits']\n",
      "===========================\n",
      "8 13\n",
      "Similar to SARS-CoV , SARS-CoV-2 exploits angiotensin-converting enzyme 2 ( ACE2 ) as a receptor to invade cells , notably type II alveolar epithelial cells .\n",
      "['[c]cells', 'cells', 'epithelial', 'alveolar', 'receptor', 'a', 'to', 'invade', '[c]SARS-CoV', 'as']\n",
      "===========================\n",
      "8 14\n",
      "The SARS-Cov-2 first predominantly infects lower airways and binds to ACE2 on alveolar epithelial cells .\n",
      "['SARS-Cov-2', 'ACE2', '[c]The', '[c]The', '[c]The', 'first', '[c]The', 'predominantly', 'alveolar', 'lower']\n",
      "===========================\n",
      "8 14\n",
      "The SARS-Cov-2 first predominantly infects lower airways and binds to ACE2 on alveolar epithelial cells .\n",
      "['airways', 'alveolar', 'cells', 'epithelial', 'lower', 'The', 'and', 'infects', '[c]predominantly', 'on']\n",
      "===========================\n",
      "8 15\n",
      "Like a related coronavirus that emerged in 2003 , SARS-CoV-2 enters human cells by binding to the extracellular domain of Angiotensin Converting Enzyme 2 ( ACE2 ) [ 14 , 15 ] .\n",
      "['SARS-CoV-2', '2', 'ACE2', ',', ',', 'human', ',', '[', 'of', 'related']\n",
      "===========================\n",
      "8 15\n",
      "Like a related coronavirus that emerged in 2003 , SARS-CoV-2 enters human cells by binding to the extracellular domain of Angiotensin Converting Enzyme 2 ( ACE2 ) [ 14 , 15 ] .\n",
      "['cells', 'human', '[', 'by', 'extracellular', 'of', 'related', 'binding', 'to', 'related']\n",
      "===========================\n",
      "8 16\n",
      "The primary target of SARS-CoV-2 is the upper respiratory mucosa , and angiotensin-converting enzyme 2 ( ACE2 ) acts as a functional receptor for the viral spikes and eventually viral entry into host cells .\n",
      "['SARS-CoV-2', '2', 'ACE2', 'of', 'viral', 'of', 'spikes', 'of', 'the', 'viral']\n",
      "===========================\n",
      "8 16\n",
      "The primary target of SARS-CoV-2 is the upper respiratory mucosa , and angiotensin-converting enzyme 2 ( ACE2 ) acts as a functional receptor for the viral spikes and eventually viral entry into host cells .\n",
      "['cells', 'host', 'respiratory', 'viral', 'the', '[c]target', 'receptor', 'is', 'primary', 'upper']\n",
      "===========================\n",
      "8 17\n",
      "Studies have shown that SARS-CoV-2 infects the GI tract via its viral receptor angiotensin converting enzyme II , which is expressed on enterocytes of the ileum and colon .\n",
      "['SARS-CoV-2', 'II', 'that', 'that', 'viral', '[c]Studies', 'that', 'is', 'that', 'SARS-CoV-2']\n",
      "===========================\n",
      "8 17\n",
      "Studies have shown that SARS-CoV-2 infects the GI tract via its viral receptor angiotensin converting enzyme II , which is expressed on enterocytes of the ileum and colon .\n",
      "['tract', '[p]GI', '[c]Studies', 'that', 'on', 'the', '[p]is', 'the', 'its', '[p]and']\n",
      "===========================\n",
      "8 18\n",
      "Presumably , SARS-CoV infects cells through the S protein , which binds to cell surface receptor-angiotensin-converting enzyme 2 [ 4 ] .\n",
      "['2', 'SARS-CoV', 'S', '[', 'the', 'cells', 'which', '[c],', 'SARS-CoV', 'infects']\n",
      "===========================\n",
      "8 18\n",
      "Presumably , SARS-CoV infects cells through the S protein , which binds to cell surface receptor-angiotensin-converting enzyme 2 [ 4 ] .\n",
      "['cells', 'cell', '[', 'infects', 'surface', 'surface', 'which', '[c]Presumably', 'SARS-CoV', 'the']\n",
      "===========================\n",
      "8 19\n",
      "SARS-CoV-2 enters respiratory epithelial cells by attaching to angiotensin converting enzyme-2 ( ACE-2 ) via S-protein ; ACE-2 is also a receptor for SARS-CoV-1 [ 27 ] .\n",
      "['[c]SARS-CoV-2', 'SARS-CoV-1', 'ACE-2', 'ACE-2', 'enzyme-2', 'for', 'is', '[', 'respiratory', 'for']\n",
      "===========================\n",
      "8 19\n",
      "SARS-CoV-2 enters respiratory epithelial cells by attaching to angiotensin converting enzyme-2 ( ACE-2 ) via S-protein ; ACE-2 is also a receptor for SARS-CoV-1 [ 27 ] .\n",
      "['cells', 'epithelial', '[c]respiratory', 'is', '[', 'by', 'receptor', '[c]enters', ';', 'SARS-CoV-1']\n",
      "===========================\n",
      "8 20\n",
      "Like other coronaviruses , SARS-CoV-2 recognizes the human Angiotensin Converting Enzyme 2 ( hACE2 ) as a cellular receptor that allows it to infect different host cells , and likely disrupts the renin-angiotensin-aldosterone system ( RAAS ) homeostasis .\n",
      "['SARS-CoV-2', 'hACE2', '2', ',', ',', 'it', 'likely', 'the', 'a', ',']\n",
      "===========================\n",
      "8 20\n",
      "Like other coronaviruses , SARS-CoV-2 recognizes the human Angiotensin Converting Enzyme 2 ( hACE2 ) as a cellular receptor that allows it to infect different host cells , and likely disrupts the renin-angiotensin-aldosterone system ( RAAS ) homeostasis .\n",
      "['cells', 'host', 'different', 'cellular', 'receptor', 'it', 'a', 'the', 'homeostasis', 'the']\n",
      "===========================\n",
      "8 21\n",
      "Like a related coronavirus that emerged in 2003 ( Li et al. , 2003 ) , SARS-CoV-2 enters human cells by binding to the extracellular domain of Angiotensin Converting Enzyme 2 ( ACE2 ) ( Hoffmann et al. , 2020 ; Zhou et al. , 2020 ) .\n",
      "['SARS-CoV-2', '2', 'ACE2', ',', ',', 'human', ')', 'related', ',', 'of']\n",
      "===========================\n",
      "8 21\n",
      "Like a related coronavirus that emerged in 2003 ( Li et al. , 2003 ) , SARS-CoV-2 enters human cells by binding to the extracellular domain of Angiotensin Converting Enzyme 2 ( ACE2 ) ( Hoffmann et al. , 2020 ; Zhou et al. , 2020 ) .\n",
      "['cells', 'human', 'by', 'related', 'extracellular', '(', 'of', 'related', '[c]Like', 'binding']\n",
      "===========================\n",
      "8 22\n",
      "SARS-CoV-2 predominantly invades alveolar epithelial cells by binding to the ACE-2 receptor and then replicates within cells .\n",
      "['[c]SARS-CoV-2', 'ACE-2', 'predominantly', 'then', 'replicates', 'alveolar', 'receptor', 'epithelial', 'predominantly', 'the']\n",
      "===========================\n",
      "8 22\n",
      "SARS-CoV-2 predominantly invades alveolar epithelial cells by binding to the ACE-2 receptor and then replicates within cells .\n",
      "['cells', 'cells', '[c]alveolar', 'epithelial', '[c]predominantly', 'receptor', 'within', 'then', 'the', 'by']\n",
      "===========================\n",
      "8 23\n",
      "In pulmonary tissue , SARS-CoV-2 interacts with a membrane protein , Angiotensin Converting Enzyme 2 ( ACE-2 ) , to enter the host s cells [ 2 ] .\n",
      "['SARS-CoV-2', 'ACE-2', '2', '2', ',', ',', 'tissue', '[c]In', ',', 'pulmonary']\n",
      "===========================\n",
      "8 23\n",
      "In pulmonary tissue , SARS-CoV-2 interacts with a membrane protein , Angiotensin Converting Enzyme 2 ( ACE-2 ) , to enter the host s cells [ 2 ] .\n",
      "['cells', '[c]tissue', '[c]pulmonary', 'In', 'host', 's', 'membrane', '[', 'a', 'enter']\n",
      "===========================\n",
      "8 24\n",
      "SARS-CoV-2 is considered a lower respiratory tract pathogen that gains access to the body by binding to the angiotensin-converting enzyme 2 ( ACE-2 ) on the surface of alveolar epithelial type II cells ( 2 ) .\n",
      "['[c]SARS-CoV-2', '2', 'ACE-2', '2', 'is', 'pathogen', 'that', 'a', 'II', 'alveolar']\n",
      "===========================\n",
      "8 24\n",
      "SARS-CoV-2 is considered a lower respiratory tract pathogen that gains access to the body by binding to the angiotensin-converting enzyme 2 ( ACE-2 ) on the surface of alveolar epithelial type II cells ( 2 ) .\n",
      "['body', 'alveolar', 'cells', 'of', '[c]is', 'access', 'epithelial', 'that', 'respiratory', 'the']\n",
      "===========================\n",
      "8 25\n",
      "SARS-CoV-2 binds to the ACE2 receptor on ciliated bronchial epithelial cells to gain entry into these cells for viral replication and dissemination in the airway and systemically .\n",
      "['[c]SARS-CoV-2', 'ACE2', 'viral', 'binds', 'and', 'entry', 'receptor', 'and', 'bronchial', 'the']\n",
      "===========================\n",
      "8 25\n",
      "SARS-CoV-2 binds to the ACE2 receptor on ciliated bronchial epithelial cells to gain entry into these cells for viral replication and dissemination in the airway and systemically .\n",
      "['cells', 'cells', 'these', 'epithelial', 'bronchial', 'viral', 'airway', 'receptor', '[c]the', 'entry']\n",
      "===========================\n",
      "9 0\n",
      "Human angiotensin-converting enzyme 2 ( ACE2 ) is a functional receptor hijacked by  SARS-CoV-2 for cell entry , similar to SARS-CoV [ 8 , 16 ] .\n",
      "['SARS-CoV-2', '2', '[p]ACE2', 'SARS-CoV', 'is', '[p]', 'entry', 'cell', '[p]', '[']\n",
      "===========================\n",
      "9 0\n",
      "Human angiotensin-converting enzyme 2 ( ACE2 ) is a functional receptor hijacked by  SARS-CoV-2 for cell entry , similar to SARS-CoV [ 8 , 16 ] .\n",
      "['ACE2', '[p]2', '[c]enzyme', '[c]Human', 'receptor', 'cell', '[p]SARS-CoV-2', 'is', '(', '[p]angiotensin-converting']\n",
      "===========================\n",
      "9 1\n",
      "Molecularly , like SARS-CoV , the  SARS-CoV-2 virus likely uses ACE-2 as entry receptor , which is highly expressed in the lung and gastrointestinal tract [ 10 ] [ 11 ] [ 12 ] .\n",
      "['[p]SARS-CoV-2', 'ACE-2', 'virus', 'SARS-CoV', '[p]', 'likely', '[p]', '[p]', 'receptor', 'entry']\n",
      "===========================\n",
      "9 1\n",
      "Molecularly , like SARS-CoV , the  SARS-CoV-2 virus likely uses ACE-2 as entry receptor , which is highly expressed in the lung and gastrointestinal tract [ 10 ] [ 11 ] [ 12 ] .\n",
      "['ACE-2', 'receptor', 'entry', 'SARS-CoV-2', 'uses', 'uses', 'is', 'virus', 'as', 'lung']\n",
      "===========================\n",
      "9 2\n",
      "SARS-CoV-2 enters respiratory epithelial cells by attaching to angiotensin converting enzyme-2 ( ACE-2 ) via S-protein ; ACE-2 is also a receptor for SARS-CoV-1 [ 27 ] .\n",
      "['[c]SARS-CoV-2', 'SARS-CoV-1', 'ACE-2', 'ACE-2', 'enzyme-2', 'for', 'is', '[', 'respiratory', 'for']\n",
      "===========================\n",
      "9 2\n",
      "SARS-CoV-2 enters respiratory epithelial cells by attaching to angiotensin converting enzyme-2 ( ACE-2 ) via S-protein ; ACE-2 is also a receptor for SARS-CoV-1 [ 27 ] .\n",
      "['SARS-CoV-2', '[p]is', '[c]epithelial', 'ACE-2', '[p]receptor', 'angiotensin', '[c]enzyme-2', 'respiratory', '[', '[c];']\n",
      "===========================\n",
      "9 3\n",
      "With regard to  COVID-19 , it is known that the angiotensin-converting enzyme 2 ( ACE2 ) ACE2 provides the cell membrane receptor entry point for SARS-CoV-2 .\n",
      "['SARS-CoV-2', 'COVID-19', 'ACE2', '2', 'ACE2', 'for', '', '', 'receptor', '']\n",
      "===========================\n",
      "9 3\n",
      "With regard to  COVID-19 , it is known that the angiotensin-converting enzyme 2 ( ACE2 ) ACE2 provides the cell membrane receptor entry point for SARS-CoV-2 .\n",
      "['ACE2', 'cell', '[p]the', '[c]receptor', 'ACE2', 'SARS-CoV-2', 'membrane', '[p]2', '[p]the', ')']\n",
      "===========================\n",
      "9 4\n",
      "It is now known that  SARS-CoV-2 utilizes the same receptor of SARS-CoV , which is angiotensin converting enzyme II ( ACE2 ) for viral entry into the host cells [ 5 , 40 ] .\n",
      "['SARS-CoV-2', 'ACE2', '[p]', 'SARS-CoV', 'viral', '[p]', 'II', 'same', '[p]', '[p]receptor']\n",
      "===========================\n",
      "9 4\n",
      "It is now known that  SARS-CoV-2 utilizes the same receptor of SARS-CoV , which is angiotensin converting enzyme II ( ACE2 ) for viral entry into the host cells [ 5 , 40 ] .\n",
      "['ACE2', 'angiotensin', 'II', 'receptor', '[c]SARS-CoV-2', 'viral', 'enzyme', '(', 'same', 'host']\n",
      "===========================\n",
      "9 5\n",
      "Both SARS-CoV and SARS-CoV-2 infect human respiratory epithelial cells through the interaction of spike protein with human ACE2 , and only cells expressing ACE2 can be infected with SARS-CoV-2 in vitro [ 25 ] .\n",
      "['[p]SARS-CoV-2', 'SARS-CoV-2', 'ACE2', '[c]Both', '[p]ACE2', 'SARS-CoV', 'protein', 'and', 'human', 'with']\n",
      "===========================\n",
      "9 5\n",
      "Both SARS-CoV and SARS-CoV-2 infect human respiratory epithelial cells through the interaction of spike protein with human ACE2 , and only cells expressing ACE2 can be infected with SARS-CoV-2 in vitro [ 25 ] .\n",
      "['ACE2', '[c]ACE2', 'human', 'expressing', 'protein', 'human', '[c]Both', 'SARS-CoV-2', 'SARS-CoV-2', 'epithelial']\n",
      "===========================\n",
      "9 6\n",
      "Like a related coronavirus that emerged in 2003 ( Li et al. , 2003 ) ,  SARS-CoV-2 enters human cells by binding to the extracellular domain of Angiotensin Converting Enzyme 2 ( ACE2 ) ( Hoffmann et al. , 2020 ; Zhou et al. , 2020 ) .\n",
      "['SARS-CoV-2', '2', 'ACE2', '', '', 'human', 'related', '', 'cells', ')']\n",
      "===========================\n",
      "9 6\n",
      "Like a related coronavirus that emerged in 2003 ( Li et al. , 2003 ) ,  SARS-CoV-2 enters human cells by binding to the extracellular domain of Angiotensin Converting Enzyme 2 ( ACE2 ) ( Hoffmann et al. , 2020 ; Zhou et al. , 2020 ) .\n",
      "['ACE2', '2', 'Enzyme', 'Angiotensin', 'SARS-CoV-2', 'of', 'extracellular', '(', '[p]human', ')']\n",
      "===========================\n",
      "9 7\n",
      "SARS-CoV-2 , much like the structurally similar and precedent SARS-CoV , uses the ACE2 receptor to establish host uptake [ 2 ] .\n",
      "['[c]SARS-CoV-2', 'ACE2', '2', 'SARS-CoV', 'uptake', 'receptor', 'host', '[', 'the', 'the']\n",
      "===========================\n",
      "9 7\n",
      "SARS-CoV-2 , much like the structurally similar and precedent SARS-CoV , uses the ACE2 receptor to establish host uptake [ 2 ] .\n",
      "['ACE2', 'receptor', 'host', 'the', '[c]SARS-CoV-2', 'the', 'uptake', '[', '2', 'establish']\n",
      "===========================\n",
      "9 8\n",
      "SARS-CoV-2 seems to use the same cell entry receptor , ACE2 , as the SARS-CoV because ACE2 shows binding to RBD of both SARS-CoV and SARS-CoV-2 [ 11 ] .\n",
      "['[c]SARS-CoV-2', 'SARS-CoV-2', 'ACE2', 'ACE2', 'SARS-CoV', 'and', 'both', 'SARS-CoV', 'seems', 'of']\n",
      "===========================\n",
      "9 8\n",
      "SARS-CoV-2 seems to use the same cell entry receptor , ACE2 , as the SARS-CoV because ACE2 shows binding to RBD of both SARS-CoV and SARS-CoV-2 [ 11 ] .\n",
      "['ACE2', 'cell', 'ACE2', 'receptor', ',', 'because', '[c]SARS-CoV-2', 'SARS-CoV-2', 'entry', 'of']\n",
      "===========================\n",
      "9 9\n",
      "SARS-CoV-2 exploits the ACE-2 receptor , the same receptor as SARS , in the human lower respiratory tract for entry into lung cells [ 41 , 42 ] .\n",
      "['[c]SARS-CoV-2', 'ACE-2', 'lung', 'receptor', '[', 'entry', 'human', 'the', 'the', 'exploits']\n",
      "===========================\n",
      "9 9\n",
      "SARS-CoV-2 exploits the ACE-2 receptor , the same receptor as SARS , in the human lower respiratory tract for entry into lung cells [ 41 , 42 ] .\n",
      "['ACE-2', 'receptor', '[c]SARS-CoV-2', 'the', 'the', 'receptor', 'lung', 'the', 'entry', '[']\n",
      "===========================\n",
      "9 10\n",
      "Similar to severe acute respiratory syndrome-associated coronavirus ( SARS-CoV ) 16 , 17 , the SARS-CoV-2 employs angiotensin-converting enzyme-2 ( ACE2 ) as a receptor for cellular entry .\n",
      "['SARS-CoV-2', 'enzyme-2', 'ACE2', 'the', 'the', 'entry', 'the', 'SARS-CoV', 'cellular', 'receptor']\n",
      "===========================\n",
      "9 10\n",
      "Similar to severe acute respiratory syndrome-associated coronavirus ( SARS-CoV ) 16 , 17 , the SARS-CoV-2 employs angiotensin-converting enzyme-2 ( ACE2 ) as a receptor for cellular entry .\n",
      "['ACE2', '[p]employs', 'enzyme-2', '(', 'receptor', 'SARS-CoV-2', 'angiotensin-converting', 'entry', 'a', 'cellular']\n",
      "===========================\n",
      "9 11\n",
      "Like SARS-CoV , 2019-nCoV may use angiotensin-converting enzyme 2 ( ACE2 ) as a potential receptor for host cell infectivity [ 17 ] .\n",
      "['2', 'ACE2', 'SARS-CoV', '[c]2019-nCoV', ',', 'infectivity', 'may', '[', 'host', ',']\n",
      "===========================\n",
      "9 11\n",
      "Like SARS-CoV , 2019-nCoV may use angiotensin-converting enzyme 2 ( ACE2 ) as a potential receptor for host cell infectivity [ 17 ] .\n",
      "['ACE2', '2', 'use', 'cell', 'enzyme', 'host', '(', 'receptor', 'infectivity', 'use']\n",
      "===========================\n",
      "9 12\n",
      "The SARS-CoV-2 virus utilizes Angiotensin Converting Enzyme 2 ( ACE2 ) receptors as its cell surface receptor , similar to the SARS 2002 - 3 virus .\n",
      "['SARS-CoV-2', '2', 'ACE2', 'virus', '[c]The', '3', '[c]The', 'virus', '-', '2002']\n",
      "===========================\n",
      "9 12\n",
      "The SARS-CoV-2 virus utilizes Angiotensin Converting Enzyme 2 ( ACE2 ) receptors as its cell surface receptor , similar to the SARS 2002 - 3 virus .\n",
      "['ACE2', '2', 'Enzyme', 'Angiotensin', 'cell', '[p](', 'receptor', 'surface', '[p]Converting', '[p]SARS-CoV-2']\n",
      "===========================\n",
      "9 13\n",
      "Presumably , SARS-CoV infects cells through the S protein , which binds to cell surface receptor-angiotensin-converting enzyme 2 [ 4 ] .\n",
      "['2', 'SARS-CoV', 'S', '[', 'cells', 'the', '[c],', '[c]which', 'cell', 'infects']\n",
      "===========================\n",
      "9 13\n",
      "Presumably , SARS-CoV infects cells through the S protein , which binds to cell surface receptor-angiotensin-converting enzyme 2 [ 4 ] .\n",
      "['2', 'enzyme', 'cell', '[c]surface', '[c]surface', '[c]surface', '[', '[c]cells', '[c]receptor-angiotensin-converting', 'to']\n",
      "===========================\n",
      "9 14\n",
      "SARS-CoV-2 utilizes ACE2 as a receptor for entry into the host pneumocytes [ 13 ] .\n",
      "['[c]SARS-CoV-2', 'ACE2', 'entry', '[', 'utilizes', 'host', 'a', 'receptor', 'host', 'as']\n",
      "===========================\n",
      "9 14\n",
      "SARS-CoV-2 utilizes ACE2 as a receptor for entry into the host pneumocytes [ 13 ] .\n",
      "['ACE2', '[c]SARS-CoV-2', 'receptor', 'entry', 'utilizes', 'a', 'host', 'host', 'as', '[']\n",
      "===========================\n",
      "9 15\n",
      "Several studies also confirm that SARS-CoV-2 also leverages the ACE2 receptor to gain entry into target cells ( 5 ) ( 6 ) ( 7 ) .\n",
      "['SARS-CoV-2', 'ACE2', 'that', 'that', 'also', 'receptor', 'entry', 'that', 'that', 'studies']\n",
      "===========================\n",
      "9 15\n",
      "Several studies also confirm that SARS-CoV-2 also leverages the ACE2 receptor to gain entry into target cells ( 5 ) ( 6 ) ( 7 ) .\n",
      "['ACE2', 'receptor', '[p]SARS-CoV-2', 'entry', 'target', 'the', 'the', 'cells', 'into', '[p]also']\n",
      "===========================\n",
      "9 16\n",
      "The receptor-binding motif of 2019-nCoV has undergone modification SARS-CoV and 2019-nCoV enter the cell in the same waythrough binding ACE2 , which is present in lung and gastrointestinal epithelia [ 30 ] .\n",
      "['ACE2', '[c]SARS-CoV', 'and', 'of', 'has', 'The', '2019-nCoV', 'of', '2019-nCoV', 'The']\n",
      "===========================\n",
      "9 16\n",
      "The receptor-binding motif of 2019-nCoV has undergone modification SARS-CoV and 2019-nCoV enter the cell in the same waythrough binding ACE2 , which is present in lung and gastrointestinal epithelia [ 30 ] .\n",
      "['ACE2', '[c]The', '[c]The', 'cell', 'binding', 'of', 'lung', 'has', 'is', '[']\n",
      "===========================\n",
      "9 17\n",
      "Similar to SARS , SARS-CoV-2 is believed to invade the host through the cell entry receptor ACE2 [ 4 ] .\n",
      "['SARS-CoV-2', 'ACE2', ',', 'is', ',', 'host', '[', 'receptor', 'cell', ',']\n",
      "===========================\n",
      "9 17\n",
      "Similar to SARS , SARS-CoV-2 is believed to invade the host through the cell entry receptor ACE2 [ 4 ] .\n",
      "['ACE2', 'cell', '[c]SARS-CoV-2', 'host', 'receptor', 'the', 'entry', '[', 'receptor', '[p]is']\n",
      "===========================\n",
      "9 18\n",
      "Similar to SARS-CoV , SARS-CoV-2 exploits angiotensin-converting enzyme 2 ( ACE2 ) as a receptor to invade cells , notably type II alveolar epithelial cells .\n",
      "['SARS-CoV-2', '2', 'ACE2', 'SARS-CoV', ',', ',', 'alveolar', 'a', 'exploits', 'receptor']\n",
      "===========================\n",
      "9 18\n",
      "Similar to SARS-CoV , SARS-CoV-2 exploits angiotensin-converting enzyme 2 ( ACE2 ) as a receptor to invade cells , notably type II alveolar epithelial cells .\n",
      "['ACE2', '2', 'exploits', 'enzyme', '(', '[p]SARS-CoV-2', 'a', 'receptor', 'alveolar', 'epithelial']\n",
      "===========================\n",
      "9 19\n",
      "Both SARS-CoV and SARS-CoV-2 bind to the ACE2 receptor through the Spike ( S ) protein ( Kuba et al. , 2005 ; Yan et al. , 2020 ) .\n",
      "['SARS-CoV-2', 'ACE2', 'SARS-CoV', '[c]Both', '[c]and', '[c]and', '[c]and', 'receptor', '[c]Both', '(']\n",
      "===========================\n",
      "9 19\n",
      "Both SARS-CoV and SARS-CoV-2 bind to the ACE2 receptor through the Spike ( S ) protein ( Kuba et al. , 2005 ; Yan et al. , 2020 ) .\n",
      "['ACE2', 'receptor', '[c]Both', 'SARS-CoV-2', 'the', 'the', '(', '[p]to', 'and', '[p]bind']\n",
      "===========================\n",
      "9 20\n",
      "Further extensive structural analysis strongly suggests that SARS-CoV-2 may use host receptor angiotensin-converting enzyme 2 ( ACE2 ) to enter the cells [ 42 ] , the same receptor facilitating SARS-CoV to infect the airway epithelium and alveolar type 2 ( AT2 ) pneumocytes , pulmonary cells that synthesize pulmonary surfactant [ 43 ] .\n",
      "['SARS-CoV-2', '2', 'SARS-CoV', 'ACE2', '2', 'that', 'that', 'extensive', 'AT2', '[c]Further']\n",
      "===========================\n",
      "9 20\n",
      "Further extensive structural analysis strongly suggests that SARS-CoV-2 may use host receptor angiotensin-converting enzyme 2 ( ACE2 ) to enter the cells [ 42 ] , the same receptor facilitating SARS-CoV to infect the airway epithelium and alveolar type 2 ( AT2 ) pneumocytes , pulmonary cells that synthesize pulmonary surfactant [ 43 ] .\n",
      "['[p]host', '2', 'receptor', 'ACE2', 'receptor', 'SARS-CoV-2', 'enzyme', 'use', 'receptor', '[c]extensive']\n",
      "===========================\n"
     ]
    }
   ],
   "source": [
    "query2sent2gold = load_gold()\n",
    "good, bad = 0., 0.\n",
    "good2, bad2 =  0., 0.\n",
    "\n",
    "def is_correct(ind, start_and_end, relevant):\n",
    "    \n",
    "    is_in_phrase = False\n",
    "    is_relevant = False\n",
    "    \n",
    "    for (start, end) in start_and_end:\n",
    "        \n",
    "        if ind >= start and ind <= end:\n",
    "            \n",
    "            is_in_phrase = True\n",
    "            if ind in relevant:\n",
    "                is_relevant = True\n",
    "    \n",
    "    return is_in_phrase, is_relevant\n",
    "        \n",
    "        \n",
    "        \n",
    "\n",
    "for query in query2arg2preds.keys():\n",
    "    \n",
    "    fname = \"results{}.txt\".format(query)\n",
    "    \n",
    "    for sent_ind in range(len(query2arg2preds[query][0])):\n",
    "        \n",
    "        if sent_ind >= len(query2sent2gold[query].keys()): break\n",
    "        \n",
    "        for arg in range(2):\n",
    "            #if arg == 0: print(query2arg2preds[query][arg][sent_ind][\"sent\"])\n",
    "            d = query2arg2preds[query][arg][sent_ind]\n",
    "            mask_relevant =  np.array(d[\"pred_idx\"]) != -1\n",
    "            idx_relevant, sims_relevant = np.array(d[\"pred_idx\"])[mask_relevant], np.array(d[\"preds_sims\"])[mask_relevant]\n",
    "            word_pred = [d[\"sent\"].split(\" \")[j] for j in idx_relevant]\n",
    "            \n",
    "            arg_key = \"arg1\" if arg == 0 else \"arg2\"\n",
    "\n",
    "            if query2sent2gold[query][sent_ind][arg_key] == []: continue\n",
    "             \n",
    "            in_phrae_and_relevant = [is_correct(idx_relevant[k], query2sent2gold[query][sent_ind][arg_key], query2sent2gold[query][sent_ind][\"relevant\"]) for k in range(len(idx_relevant))]\n",
    "            in_phrase, relevant = list(zip(*in_phrae_and_relevant))\n",
    "            preds_annotated = []\n",
    "            for k,w in zip(idx_relevant, word_pred):\n",
    "                \n",
    "                if in_phrase[k] and relevant[k]:\n",
    "                    \n",
    "                    w = \"[c]\"+w\n",
    "                if in_phrase[k] and not relevant[k]:\n",
    "                    w = \"[p]\" + w\n",
    "                \n",
    "                preds_annotated.append(w)\n",
    "            \n",
    "            print(query, sent_ind)\n",
    "            print(d[\"sent\"])\n",
    "            print(preds_annotated[:10])\n",
    "            print(\"===========================\")\n",
    "                \n",
    "                \n",
    "            \n",
    "            if in_phrase[1]:\n",
    "                good2 += 1\n",
    "            else:\n",
    "                bad2 += 1\n",
    "                \n",
    "            for (start,end) in query2sent2gold[query][sent_ind][arg_key]:\n",
    "                if idx_relevant[0] >=  start and idx_relevant[0] <= end:\n",
    "                     good += 1\n",
    "                     break\n",
    "            else:\n",
    "                    bad += 1\n",
    "                    \"\"\" \n",
    "                    print(\"query:\", query)\n",
    "                    print(\"sent_ind:\", sent_ind)\n",
    "                    print(d[\"sent\"])\n",
    "                    print(\"preds:\", word_pred[:5])\n",
    "                    print(\"argument:\", arg_key)\n",
    "                    print(\"gold:\", query2sent2gold[query][sent_ind][arg_key])\n",
    "                    print(\"pred:\", idx_relevant[:5])\n",
    "                    print(\"======================\")\n",
    "                    \"\"\"\n",
    "        \n",
    "        #print(\"============================\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(311.0, 185.0, 91.0, 217.0)"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "good, good2, bad, bad2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.4601990049751244"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "good2/(good2+bad2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.7736318407960199"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "good / (good + bad)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
